TSS:Rfhg 162034.1

Basic information about the TSS

---

TSS ID: rfhg_162034.1 TSS ID(Version3): hg_135763.1 Species: human Chr: chr13		Start: 98143411 End: 98143424 Strand: +
Source datasets	FANTOM5|PRJNA4843412|DRA013844
Protocol	CAGE|NETCAGE
TSS cluster detected*	3

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2682652,EH38E1691300)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000596580.2:0 GeneID: 10160 HGNC/MGI_ID: HGNC:3591 UniProt_ID: A0A1B0GV68 Nearer transcript ids and distances:

Gene_name: FARP1 Gene_symbol: FARP1 Gene_synonyms: CDEP GLCC1 MGC87400 PLEKHC2 PPP1R75 Gene_source: HGNC:3591

TATA-Box annotation

---

Distance to TSS:	323
Nearest PromoterID:	NM_005766
Entrez ID:	10160
Nearest Unigene:	Hs.403917
Nearest Refseq:	NM_005766
Nearest Ensembl:	ENSG00000152767
Gene Name:	FARP1
Gene Alias:	CDEP|FARP1-IT1|PLEKHC2|PPP1R75
Gene Type:	protein-coding
CpG%:	0.230769
GC%:	0.928571
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@FARP1 p2@FARP1 p3@FARP1 p4@FARP1 p5@FARP1 p6@FARP1 p7@FARP1 p8@FARP1 p9@FARP1 p10@FARP1
Sample		p1@FARP1	p2@FARP1	p3@FARP1	p4@FARP1	p5@FARP1	p6@FARP1	p7@FARP1	p8@FARP1	p9@FARP1	p10@FARP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	20.26	4.48	2.14	1.56	0.39	0.00	0.00	0.00	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	21.04	3.64	1.42	1.42	0.20	0.81	0.40	0.00	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	21.41	4.05	2.12	1.35	0.19	0.39	0.58	0.00	0.19	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	22.25	3.53	1.46	0.21	0.00	0.42	0.00	0.00	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	19.35	3.37	1.35	1.57	0.22	0.22	0.22	0.00	0.22	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	16.28	4.26	0.58	0.97	0.19	0.58	0.39	0.19	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	21.13	4.58	1.31	0.65	0.00	0.22	0.22	0.00	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	22.04	3.15	4.60	1.70	0.48	0.48	0.00	0.24	0.24	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	21.59	4.92	2.35	1.92	0.85	1.07	0.85	0.00	0.00	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	19.71	2.90	1.16	1.74	1.16	1.74	0.58	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	19.81	2.83	2.02	0.81	0.81	0.81	0.81	0.40	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	21.95	4.88	0.81	0.00	1.63	0.81	0.81	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	40.94	9.83	5.64	2.26	1.13	1.45	0.00	0.00	0.64	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	28.57	7.37	4.51	1.50	0.30	0.60	0.15	0.00	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	41.93	6.37	4.61	0.88	1.10	0.66	0.00	0.00	0.22	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	35.21	5.53	3.27	0.25	0.25	0.75	0.00	0.00	0.50	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	31.89	4.59	3.28	0.44	0.44	0.22	0.00	0.00	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	26.57	6.33	2.11	1.69	0.00	0.00	0.42	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	26.12	4.27	3.73	0.53	0.53	0.53	0.00	0.00	2.13	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	30.99	7.52	3.61	0.90	0.75	0.45	0.00	0.00	0.00	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	28.07	5.08	3.74	1.47	0.27	0.67	0.00	0.00	0.53	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	27.79	5.18	5.35	1.04	0.69	0.52	0.00	0.00	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	30.63	5.17	4.14	1.94	0.52	0.26	0.13	0.00	0.13	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	29.61	5.58	2.91	1.94	0.49	0.49	0.00	0.00	1.21	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	34.05	5.42	5.68	1.03	0.26	0.00	0.00	0.00	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	31.65	3.80	7.28	1.27	0.32	0.32	0.00	0.00	0.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	19.78	5.49	6.59	1.65	0.00	0.00	0.00	0.00	0.55	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	28.29	12.26	3.30	0.71	1.18	1.65	0.00	0.00	0.47	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	26.49	6.62	4.20	0.81	0.97	0.97	0.00	0.00	0.65	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	31.85	8.51	5.25	0.90	0.36	0.36	0.00	0.00	0.72	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	30.15	5.86	4.61	1.26	0.63	0.84	0.00	0.00	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	35.95	7.42	4.69	1.37	0.98	0.59	0.00	0.00	0.39	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	28.70	6.96	3.38	1.27	0.63	0.21	0.00	0.00	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	23.42	4.29	4.29	0.66	0.33	1.32	0.00	0.00	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	30.48	10.10	3.18	1.68	0.19	1.12	0.00	0.00	0.37	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	37.75	8.62	2.87	1.92	0.96	0.77	0.00	0.00	0.38	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	34.34	9.81	3.07	1.84	0.82	0.41	0.00	0.00	0.61	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	27.20	7.66	2.62	0.81	1.21	0.60	0.00	0.00	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	40.79	8.64	6.48	1.08	0.81	1.08	0.00	0.00	0.81	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	29.29	6.48	4.56	2.64	1.92	0.72	0.00	0.00	1.44	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	26.58	4.94	5.88	1.18	0.94	1.41	0.00	0.00	0.71	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	24.89	6.73	4.10	1.17	0.44	1.02	0.00	0.00	0.44	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	35.64	5.69	6.54	2.53	0.84	0.42	0.21	0.00	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	30.25	7.17	6.12	1.40	0.35	0.52	0.00	0.00	0.70	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	37.54	8.03	5.22	1.00	1.00	0.80	0.20	0.00	0.40	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	37.46	8.14	5.58	0.70	0.47	0.93	0.00	0.00	0.00	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	40.78	4.56	4.32	1.68	0.48	0.00	0.00	0.00	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	32.49	8.05	5.07	2.68	0.30	0.89	0.00	0.00	0.89	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	40.69	8.62	4.31	2.39	1.20	0.00	0.00	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	32.15	6.87	6.07	0.61	0.40	0.20	0.00	0.00	0.40	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	38.12	5.74	4.30	1.43	0.41	0.61	0.00	0.00	0.41	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	37.36	6.67	4.23	0.89	0.67	0.44	0.00	0.00	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	0.00	13.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	34.07	6.74	3.19	1.06	1.06	0.71	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	35.13	3.98	2.98	0.66	0.33	0.33	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	23.49	4.19	5.03	0.00	0.00	0.84	0.00	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	29.85	6.89	1.84	1.38	0.92	0.00	0.00	0.00	1.38	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	42.46	4.86	3.57	1.30	1.62	0.32	0.00	0.00	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	31.80	5.78	3.53	0.64	0.96	0.64	0.00	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	31.43	6.60	3.14	1.89	0.00	0.31	0.00	0.00	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	37.37	5.64	6.35	1.41	0.00	0.71	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	25.80	3.93	5.61	0.56	0.00	1.68	0.00	0.00	1.68	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	71.65	8.76	5.57	1.59	0.80	1.59	0.00	0.00	1.59	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	45.53	5.44	3.74	1.02	0.00	1.02	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	56.21	6.82	3.25	1.62	0.32	0.97	0.00	0.00	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	55.02	8.87	3.55	1.06	0.35	0.71	0.00	0.00	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	7.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	39.00	3.41	3.41	0.98	0.49	0.49	0.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	46.12	5.45	5.95	0.50	0.99	0.99	0.00	0.00	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	43.63	9.38	6.10	1.88	0.00	0.47	0.00	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	53.98	8.28	4.31	1.66	0.66	0.99	0.00	0.00	0.33	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	47.95	7.11	5.57	0.62	0.31	0.93	0.00	0.00	1.24	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	54.12	7.95	3.67	1.22	0.92	0.31	0.00	0.00	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	9.66	2.38	2.53	1.11	0.32	0.95	0.16	0.16	0.32	0.79
Adipocyte - breast, donor2	11327-117E4	10.91	2.25	2.09	1.28	0.32	0.00	0.00	0.00	0.64	0.32
Adipocyte - omental, donor1	11473-119C6	9.92	1.53	1.53	0.89	0.00	0.13	0.13	0.00	0.25	0.25
Adipocyte - omental, donor2	11474-119C7	15.70	4.48	0.75	3.74	0.75	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	23.11	3.35	1.67	1.34	0.33	0.33	0.67	0.00	0.67	0.33
Adipocyte - perirenal, donor1	11476-119C9	7.02	1.28	0.00	0.64	1.28	0.64	0.00	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	11.00	2.20	1.10	3.30	2.20	0.00	1.10	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	11.29	3.16	0.90	0.45	0.00	0.45	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	8.34	2.78	1.74	0.87	0.00	0.70	0.00	0.00	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	22.30	6.26	7.43	1.76	0.59	1.56	0.20	0.39	1.37	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	29.60	2.83	7.46	1.54	0.00	0.26	0.51	0.51	0.51	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	27.60	4.74	2.51	1.12	0.00	1.39	0.84	0.56	0.84	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	21.75	3.53	2.94	1.76	0.00	0.59	1.76	0.59	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	12.23	4.26	3.30	1.45	0.08	0.40	0.72	0.24	0.40	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	26.47	5.16	4.20	0.32	0.00	0.00	1.29	1.61	0.00	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	25.59	3.73	4.80	1.07	0.00	0.00	1.07	0.00	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	19.48	2.23	3.90	0.00	0.56	0.56	0.00	0.00	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	7.49	4.57	2.50	0.42	0.42	0.42	1.25	0.00	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	14.82	1.76	3.01	2.01	0.25	0.50	2.26	1.00	0.50	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	17.67	2.95	3.60	0.65	0.33	0.65	0.65	0.65	0.00	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	14.92	1.52	2.13	0.61	0.30	0.00	0.30	0.30	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	41.11	13.04	8.18	5.08	1.55	2.65	0.44	0.22	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	65.98	12.19	8.96	1.79	0.36	2.15	1.08	0.00	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	34.74	7.19	4.79	0.00	0.00	1.20	0.00	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	45.16	5.76	7.38	1.80	0.90	1.44	1.08	0.90	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	23.43	3.35	6.69	1.67	0.00	0.00	1.67	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	48.49	14.38	6.78	1.85	0.41	0.41	0.41	0.00	0.21	0.82
Anulus Pulposus Cell, donor1	11248-116E6	10.98	3.32	2.40	0.34	0.00	0.57	0.00	0.00	0.23	0.57
Anulus Pulposus Cell, donor2	11463-119B5	12.98	2.94	2.45	0.98	0.24	0.73	0.24	0.00	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	15.73	1.35	4.94	0.00	0.00	0.90	0.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	20.40	2.17	3.04	0.87	0.43	0.43	0.00	0.00	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	4.28	2.14	4.28	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	19.43	2.09	3.29	1.20	0.30	0.00	0.30	0.30	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	24.03	2.53	2.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.90	3.30	4.62	0.66	0.00	0.00	0.00	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	11.70	0.97	2.60	0.97	0.00	0.00	0.32	0.32	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	19.90	0.97	4.85	1.46	0.00	0.00	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	17.82	2.38	1.19	0.00	0.00	0.59	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	18.83	1.51	3.39	1.13	0.38	0.00	0.00	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	14.51	1.45	2.18	2.18	0.00	1.45	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	0.00	1.25	0.00	0.00	0.00	0.00	0.00	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	14.83	3.29	3.95	1.98	0.16	0.00	0.16	0.00	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	31.39	0.00	5.46	2.73	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	10.71	1.66	2.26	1.81	0.45	0.45	0.00	0.00	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	20.36	2.14	5.89	0.54	0.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	20.78	2.08	4.91	3.40	0.57	0.76	0.00	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	21.12	2.94	4.28	0.80	0.00	0.53	0.53	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	14.63	0.98	6.83	0.98	0.00	0.00	0.00	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	16.59	3.65	2.82	1.16	0.83	0.50	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	3.60	6.00	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	0.00	0.00	3.54	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	14.75	4.46	2.06	1.37	0.34	0.34	0.51	0.00	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	16.02	0.97	2.43	0.49	0.00	0.49	0.00	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	15.56	2.28	3.79	1.90	0.76	0.76	1.14	0.38	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	23.02	1.21	1.21	2.42	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	25.08	2.28	1.71	1.14	0.00	1.14	0.00	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	16.03	1.92	4.70	1.92	0.00	0.43	0.21	0.00	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	16.26	2.06	4.13	0.77	0.77	0.26	0.52	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	14.08	1.88	1.88	0.47	0.94	0.47	0.47	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	18.65	1.93	1.93	1.93	0.64	0.64	0.00	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.98	2.14	4.28	2.14	0.71	0.00	0.00	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	12.28	1.75	5.26	0.58	0.00	0.58	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	17.16	1.51	3.31	1.51	0.30	0.60	0.60	0.00	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	21.38	2.38	5.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	17.29	1.53	2.03	1.02	0.00	0.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.77	1.53	4.33	2.04	0.00	1.02	0.00	0.00	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.90	1.91	3.81	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	15.97	3.02	3.02	1.29	0.43	0.86	0.00	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	12.70	3.18	3.18	1.91	0.00	0.42	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	17.69	1.74	2.90	2.90	0.58	0.00	0.29	0.00	0.58	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	23.62	0.94	6.61	0.00	0.94	0.00	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	15.09	3.56	2.88	1.19	0.34	0.34	0.17	0.00	0.17	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	4.63	4.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	0.00	4.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	15.22	2.57	3.22	2.57	0.21	0.43	0.00	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	17.45	2.41	3.01	2.41	0.00	0.60	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	20.41	1.46	2.92	0.00	0.73	0.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	20.23	3.45	3.22	1.61	0.69	0.23	0.23	0.23	0.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	2.55	2.55	0.00	0.00	0.00	0.00	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	13.22	1.27	1.53	1.27	0.25	0.25	0.00	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	17.55	3.10	2.06	0.83	0.41	0.62	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	14.99	1.84	3.98	2.45	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	23.42	1.91	2.87	2.87	0.96	0.00	0.00	0.00	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	18.85	2.88	3.77	1.77	0.00	0.89	0.44	0.22	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	1.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	13.29	0.00	3.32	0.55	0.00	0.00	0.00	0.00	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	15.62	2.12	3.44	1.59	0.00	0.53	0.00	0.26	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	14.90	1.45	5.09	1.09	0.00	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	77.50	13.88	11.67	4.91	1.35	2.82	0.37	0.98	0.37	0.12
Astrocyte - cerebellum, donor2	11580-120F5	70.86	8.39	8.39	4.28	0.17	1.88	0.51	0.17	0.51	0.17
Astrocyte - cerebellum, donor3	11661-122F5	46.98	10.49	7.55	2.31	0.00	1.68	0.21	0.00	0.84	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	40.44	11.85	6.27	1.74	0.35	1.05	1.39	0.35	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	57.27	12.29	8.57	1.46	0.81	0.81	1.46	0.49	0.16	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	66.38	20.14	7.46	2.39	1.49	2.98	1.34	0.60	0.89	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	9.63	0.92	1.83	0.00	0.00	0.11	1.95	0.23	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	8.64	0.63	1.50	0.13	0.25	0.00	3.13	0.25	0.13	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	8.76	2.16	1.25	0.34	0.11	0.00	1.82	0.80	0.11	0.00
Basophils, donor1	12241-129G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	1.03	0.00	1.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	14.88	4.31	1.72	0.22	0.22	0.43	0.00	0.00	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	27.89	4.11	0.91	0.00	0.00	0.00	0.46	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	17.57	1.88	0.00	0.00	0.00	0.00	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	22.87	3.33	2.08	0.42	0.21	0.00	0.21	0.42	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	20.73	4.38	2.53	0.00	0.00	0.46	0.23	0.23	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	14.04	2.70	1.26	0.00	0.00	0.18	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	2.25	0.00	0.00	0.56	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	0.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	0.22	0.00	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	0.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	4.93	0.38	0.38	0.00	0.00	0.00	1.52	0.76	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	0.33	0.00	0.00	0.00	0.00	0.00	0.33	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.00	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	0.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	0.00	0.00	0.00	0.21	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.00	0.00	0.00	0.00	0.00	0.00	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	3.69	0.41	2.05	0.00	0.00	0.00	0.41	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	1.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	0.00	0.00	0.00	0.38	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	0.00	0.23	0.00	0.00	0.00	0.00	0.23	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	0.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.00	0.00	0.00	0.00	0.00	0.00	0.26	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.00	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	0.00	0.00	0.00	0.00	0.00	0.35	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.00	0.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	13.08	2.52	2.52	0.23	0.46	0.46	0.23	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.02	1.68	2.40	0.72	0.00	0.00	0.72	0.48	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	11.22	1.37	4.38	0.55	0.00	0.00	0.55	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	5.10	0.60	2.70	0.60	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	7.68	1.20	1.92	0.24	0.00	0.00	0.72	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	9.55	0.91	2.73	1.14	0.00	0.00	0.45	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	9.13	2.61	3.69	1.52	0.00	0.00	0.43	0.00	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	13.42	1.32	1.05	1.05	0.00	0.00	0.00	0.26	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	12.66	0.70	3.28	0.94	0.00	0.00	0.47	0.23	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	9.96	2.42	3.92	0.60	0.30	0.00	0.30	0.30	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	11.91	1.45	3.49	1.45	0.00	0.29	0.29	0.29	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	11.99	1.33	3.20	2.13	0.00	0.27	0.27	0.27	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	14.01	1.31	3.50	1.75	0.88	0.88	0.00	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	10.02	2.28	2.73	1.82	2.73	0.91	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	17.16	1.49	3.73	0.75	2.24	0.00	0.00	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	12.25	1.80	2.16	0.00	0.36	0.00	0.36	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	12.37	0.58	3.74	0.29	0.29	0.29	0.86	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	9.90	0.71	4.48	0.94	0.00	0.47	0.24	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	9.19	2.22	3.17	0.32	0.00	0.00	0.63	0.00	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	12.61	2.15	2.77	3.08	0.00	0.31	0.31	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	14.11	2.56	2.89	0.64	0.00	0.64	0.32	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	9.94	2.29	1.53	1.15	0.38	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	13.40	2.36	2.36	0.79	0.39	0.39	0.79	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	13.62	0.76	3.03	0.00	0.76	0.00	1.51	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	24.09	2.41	4.82	2.41	4.82	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	15.39	2.10	4.20	1.40	2.80	0.70	0.70	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	11.02	4.01	3.01	2.00	2.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	10.97	1.83	7.31	1.83	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	12.85	2.96	3.46	0.49	0.00	0.49	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	10.21	3.79	1.79	0.42	0.53	0.21	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	36.40	9.36	3.81	4.16	0.00	1.04	0.00	0.35	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	29.14	4.26	6.04	2.49	1.07	1.42	0.36	0.00	1.07	1.42
Chondrocyte - de diff, donor3	11410-118E6	19.91	9.90	3.07	3.19	0.68	0.91	0.11	0.34	0.91	0.23
Chondrocyte - re diff, donor2	11339-117F7	24.17	4.48	7.16	7.16	4.48	0.90	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	33.57	14.15	4.45	1.21	1.62	2.43	0.00	0.00	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	33.85	10.10	4.48	1.61	0.46	1.03	0.69	0.23	0.46	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	33.56	6.63	3.42	1.28	0.21	1.28	0.86	0.00	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	28.76	7.79	4.69	1.06	0.44	0.97	0.62	0.27	0.09	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	45.94	14.12	7.34	4.95	8.62	5.04	4.22	2.57	1.10	1.65
Corneal Epithelial Cells, donor1	11526-119I5	20.42	4.61	3.73	0.44	0.00	0.22	0.00	0.00	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	15.93	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	14.83	3.58	1.53	0.26	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	1.32	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	0.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	1.40	1.73	0.43	0.11	0.00	0.00	0.97	0.22	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	17.18	6.17	2.67	0.00	0.17	0.50	0.67	0.00	0.33	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	24.06	3.52	4.11	1.76	0.59	0.59	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	34.22	5.09	3.68	0.57	0.28	0.57	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	23.20	5.50	3.54	1.57	0.00	0.79	0.39	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	24.14	5.53	2.91	0.58	0.29	0.29	0.00	0.00	0.00	0.58
Endothelial Cells - Artery, donor2	11341-117F9	21.65	5.88	3.29	0.47	0.47	0.71	0.00	0.00	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	18.93	6.31	2.98	1.23	0.53	0.70	0.00	0.00	0.35	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	10.20	3.55	5.10	0.22	0.00	1.55	0.00	0.00	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	10.65	6.69	4.56	0.30	0.30	0.61	0.00	0.00	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	18.89	4.51	4.51	0.00	0.00	0.56	0.00	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	14.26	2.67	4.75	1.19	0.00	0.30	0.30	0.00	1.19	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	14.06	5.73	2.60	0.00	0.00	1.56	0.00	0.00	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	13.04	6.10	3.12	0.14	0.14	0.57	0.43	0.00	0.43	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	18.01	3.20	2.80	0.40	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	27.25	4.19	4.72	0.52	0.52	0.52	0.00	0.00	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	13.79	7.08	4.60	0.87	0.25	0.37	0.50	0.00	0.37	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	31.50	8.26	6.30	0.00	0.65	0.00	0.00	0.00	0.43	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	34.32	10.26	4.15	0.49	0.37	0.85	0.12	0.12	0.24	0.12
Endothelial Cells - Vein, donor1	11267-116G7	22.75	7.96	4.55	3.41	0.00	3.41	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	28.64	2.10	6.99	1.40	0.00	0.70	0.00	0.00	1.40	0.00
Endothelial Cells - Vein, donor3	11416-118F3	25.44	7.54	4.24	0.94	0.16	0.47	0.31	0.00	0.31	0.16
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	17.59	2.44	1.95	0.24	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	41.60	2.08	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	66.09	18.47	7.39	11.90	4.93	3.69	0.41	0.41	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	10.18	1.97	1.64	1.20	0.11	0.77	0.00	0.22	0.33	0.66
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	14.30	2.82	1.30	0.33	0.00	0.11	0.22	0.00	0.22	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	15.28	5.82	4.49	2.18	0.61	0.85	0.12	0.00	0.85	1.09
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	9.42	2.59	4.50	2.73	1.09	1.36	0.55	0.27	0.00	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	19.72	4.43	2.21	1.05	0.63	0.63	0.00	0.00	0.32	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	7.38	0.53	2.63	1.58	0.00	0.26	0.00	0.00	0.26	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	9.30	1.99	2.66	0.33	0.33	0.33	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	24.50	4.54	0.91	1.81	2.27	0.00	0.00	0.00	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	46.23	12.13	8.34	2.27	1.52	3.79	0.76	0.00	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	17.35	6.15	3.00	1.73	0.95	0.95	0.47	0.00	0.00	0.32
Fibroblast - Cardiac, donor4	11452-119A3	15.16	3.94	3.94	1.52	0.00	0.30	0.00	0.00	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	23.10	3.30	2.03	0.63	0.25	0.25	0.13	0.13	0.25	0.25
Fibroblast - Cardiac, donor6	11460-119B2	23.19	4.09	3.79	0.91	0.00	0.30	0.30	0.00	0.15	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	42.61	7.37	8.44	4.15	0.94	2.28	0.00	0.00	0.67	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	21.14	5.18	8.20	1.29	0.00	0.43	0.00	0.00	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	49.80	8.79	8.79	1.46	1.46	1.46	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	48.66	12.92	5.77	1.38	0.46	0.92	0.00	0.00	0.46	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	27.48	6.28	5.43	1.02	0.17	1.36	0.17	0.00	0.34	0.00
Fibroblast - Dermal, donor1	11269-116G9	7.51	1.17	1.41	0.23	0.00	0.00	0.00	0.00	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	11.79	3.30	2.83	1.89	0.00	0.94	0.00	0.94	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	8.10	2.42	1.81	0.48	0.00	0.24	0.00	0.00	0.24	0.00
Fibroblast - Dermal, donor4	11450-119A1	42.62	6.67	6.22	1.02	0.00	0.79	0.34	0.00	0.45	0.00
Fibroblast - Dermal, donor5	11454-119A5	55.83	8.55	6.45	3.49	0.17	0.70	0.35	0.35	0.70	0.35
Fibroblast - Dermal, donor6	11458-119A9	66.43	10.23	7.47	1.79	0.81	0.49	0.81	0.32	0.16	0.16
Fibroblast - Gingival, donor1	11237-116D4	8.95	3.12	2.71	0.21	0.00	1.04	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	58.16	13.89	11.27	8.91	2.88	3.67	0.52	0.26	4.98	1.83
Fibroblast - Gingival, donor2	11318-117D4	27.67	5.27	7.51	0.92	0.00	0.13	0.53	0.00	0.26	0.26
Fibroblast - Gingival, donor3	11394-118C8	19.53	5.70	2.80	0.77	0.19	0.87	0.19	0.00	0.19	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	41.56	14.54	11.43	6.23	3.12	1.04	2.08	0.00	6.23	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	58.68	16.92	9.51	6.70	2.82	2.29	2.64	0.88	3.52	2.64
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	37.73	8.26	5.61	3.12	1.25	1.09	0.62	0.31	1.25	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	40.57	6.76	9.33	3.92	0.68	1.08	2.43	0.54	0.95	1.22
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	169.03	22.23	13.41	8.12	2.82	4.59	3.18	2.12	4.59	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	53.67	12.58	11.41	7.75	1.90	1.46	1.17	1.17	1.46	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	46.77	6.41	6.41	7.91	0.95	0.95	0.95	0.41	1.50	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	77.88	10.20	10.64	10.31	3.07	2.30	3.18	1.10	1.21	1.76
Fibroblast - Gingival, donor9 (control)	11927-125I1	79.53	19.52	12.47	6.02	1.03	2.93	1.32	0.88	7.34	5.87
Fibroblast - Lung, donor1	11270-116H1	38.06	9.52	5.44	2.72	1.36	1.36	0.00	0.00	2.72	0.00
Fibroblast - Lung, donor2	11347-117G6	32.83	4.48	2.98	1.49	0.00	1.49	0.00	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	26.17	9.71	4.64	1.48	0.63	1.06	0.63	0.00	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	70.81	8.33	14.99	9.16	0.83	3.33	1.67	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	16.78	5.59	8.39	1.40	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	45.34	7.84	8.12	3.64	0.28	1.40	0.00	0.28	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	66.17	17.46	11.77	2.03	0.81	3.65	0.41	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	83.88	7.99	7.99	0.00	0.00	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	35.74	17.87	11.91	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	22.69	7.95	6.60	1.94	0.19	0.39	0.00	0.19	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	49.45	9.71	5.76	2.12	0.46	0.46	0.76	0.00	0.30	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	20.20	8.87	6.43	1.84	0.61	0.31	0.61	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	62.59	7.25	11.45	4.96	0.76	1.14	1.14	0.76	1.14	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	45.36	13.50	8.91	4.32	1.89	2.16	2.43	1.08	0.54	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	47.78	17.51	8.47	4.75	1.74	1.86	0.70	1.04	2.32	1.04
Fibroblast - Pulmonary Artery, donor1	11250-116E8	15.36	3.54	2.21	0.33	0.11	0.66	0.33	0.11	0.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	91.64	20.73	18.90	16.46	5.28	5.69	2.64	2.44	0.61	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	34.08	10.69	5.35	3.34	0.67	0.67	0.67	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	22.93	4.35	2.77	0.79	0.00	0.00	0.40	0.00	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	43.66	5.36	16.07	10.91	4.37	1.59	2.78	0.60	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	64.12	22.74	8.70	11.01	2.13	4.26	0.71	0.53	1.60	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	47.89	12.22	5.12	5.12	0.99	3.74	0.39	0.20	0.00	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	34.30	4.51	15.64	8.42	4.21	1.50	0.60	0.60	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	65.85	16.84	16.84	13.71	2.70	4.97	0.86	0.43	1.40	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	42.26	8.10	21.51	16.70	5.82	3.54	1.52	1.27	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	65.63	19.03	9.68	12.14	2.13	4.10	1.31	0.98	1.15	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	17.44	4.81	15.64	10.43	3.21	1.60	1.40	0.20	0.20	0.40
Fibroblast - skin normal, donor2	11561-120D4	35.86	6.63	8.74	7.74	1.91	1.41	0.70	0.10	0.50	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	48.96	5.74	22.67	13.30	2.72	1.81	2.42	0.60	0.00	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	73.40	24.69	12.76	12.68	2.07	4.81	0.58	0.83	1.24	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	23.08	5.30	5.13	0.85	0.34	1.37	0.17	0.34	0.68	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	32.84	4.60	20.03	13.47	4.27	4.27	4.27	1.64	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	57.73	14.06	9.69	10.76	3.20	2.77	1.28	1.38	0.75	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	43.18	14.68	9.45	6.24	2.70	2.36	1.18	0.84	0.34	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	42.81	14.27	4.08	4.86	0.94	1.41	0.78	0.16	1.57	1.57
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	6.97	0.87	0.87	0.87	0.00	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	6.59	1.91	1.21	0.17	0.00	0.52	0.17	0.35	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	2.34	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	7.41	1.28	1.28	0.26	0.26	0.00	0.00	0.00	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	54.35	11.48	3.06	2.30	0.00	0.00	0.77	0.77	2.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	43.39	5.10	5.10	1.91	0.00	1.91	1.91	1.28	1.28	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	70.75	14.26	7.70	2.85	0.00	0.57	0.29	0.29	3.71	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	144.22	31.71	5.52	2.76	1.93	3.86	0.28	0.00	9.10	4.41
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	93.61	14.61	8.90	5.02	5.02	3.20	1.14	0.23	5.02	4.11
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	79.85	20.41	8.12	2.18	0.59	1.39	0.40	0.00	2.97	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	126.09	30.40	8.46	2.38	0.79	2.11	1.06	0.00	8.46	5.82
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	110.56	27.07	10.76	4.57	5.22	4.89	0.98	0.33	5.54	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	35.82	12.82	4.86	1.77	0.88	1.33	0.00	0.00	2.21	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	36.74	10.18	5.09	1.27	0.28	0.99	0.71	0.14	0.71	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	42.24	10.71	2.83	1.23	0.25	0.62	0.62	0.12	0.49	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	28.47	4.30	4.57	1.07	0.27	0.00	0.27	0.54	0.81	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	44.60	13.75	4.09	1.49	0.62	0.37	0.50	0.12	0.50	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	47.48	11.49	3.32	1.38	0.14	0.42	0.97	0.42	0.28	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	32.73	5.29	2.03	1.22	0.20	0.81	0.41	0.00	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	41.98	11.41	2.74	1.60	0.23	1.14	0.91	0.00	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	53.94	14.82	3.49	1.12	0.12	0.62	0.62	0.00	1.49	1.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	45.68	13.11	5.25	2.19	0.44	1.09	0.66	0.22	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	40.48	10.93	4.43	1.77	0.59	0.59	0.89	0.00	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	53.73	13.03	3.50	2.38	0.64	1.27	1.11	0.48	1.27	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	40.66	14.08	3.35	1.12	0.89	0.89	0.67	0.22	0.45	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	55.05	10.48	6.65	1.01	1.21	1.21	0.60	0.20	1.81	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	53.61	13.23	6.96	1.87	0.68	0.51	1.36	0.17	0.17	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	43.63	9.93	7.54	2.04	0.98	1.24	1.51	0.18	0.44	0.80
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	49.43	13.32	6.45	1.25	0.31	1.46	0.42	0.10	1.04	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	46.62	9.73	6.32	0.85	0.85	1.20	1.20	0.17	2.22	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	52.67	14.72	4.76	1.66	0.89	1.33	0.89	0.11	1.11	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	39.27	9.98	7.32	2.08	0.50	1.08	1.08	0.42	0.50	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	39.41	8.37	5.31	1.63	0.61	2.04	0.82	0.20	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	45.18	11.14	4.95	0.83	0.41	1.03	0.41	0.41	0.83	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	59.72	18.79	4.73	0.92	0.12	1.61	0.46	0.12	0.12	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	60.04	15.84	7.67	2.84	1.00	2.00	0.67	0.00	0.67	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	51.58	13.67	4.19	0.66	0.88	1.10	0.66	0.00	0.88	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	54.49	17.10	4.30	1.11	0.37	1.23	0.25	0.37	0.98	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	50.09	15.72	6.65	2.43	0.97	0.65	0.97	0.32	0.49	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	39.45	9.62	2.89	0.00	0.96	0.64	0.64	0.00	0.96	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	47.76	12.51	3.79	1.42	0.47	0.57	0.57	0.00	1.14	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	66.28	15.03	4.90	1.42	0.63	0.79	1.27	0.63	1.11	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	43.79	6.39	3.65	0.61	0.30	0.30	0.91	0.30	0.91	1.82
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	41.92	12.34	6.48	1.05	0.21	0.63	1.05	0.00	0.84	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	76.41	16.91	5.49	1.10	1.10	0.66	1.10	0.00	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	41.24	6.73	3.93	1.40	0.00	0.56	1.68	0.00	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	42.31	8.98	4.35	1.20	0.00	1.39	1.11	0.19	0.65	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	50.27	8.02	5.88	1.87	0.27	1.87	1.34	0.27	0.80	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	34.73	6.73	4.44	1.68	0.15	0.61	0.77	0.31	0.31	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	41.84	9.20	5.70	1.42	0.13	0.65	1.94	0.39	0.65	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	66.96	18.43	7.86	2.17	1.36	2.17	0.81	0.54	0.54	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	57.89	11.98	7.37	2.77	0.74	0.37	0.00	0.37	0.74	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	48.47	13.82	8.11	2.63	0.44	0.88	0.66	0.22	1.54	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	191.41	37.69	15.87	4.96	3.97	4.96	0.99	0.99	2.98	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	49.86	10.82	6.73	2.11	0.26	1.85	0.66	0.40	0.53	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	38.74	9.08	5.04	1.21	0.20	0.81	0.81	0.00	0.81	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	70.91	32.28	8.90	3.56	0.00	4.57	0.25	0.25	2.03	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	41.21	9.36	4.98	1.59	0.20	1.39	0.00	0.00	0.80	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	38.36	7.55	2.77	0.46	0.62	1.08	0.31	0.15	0.15	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	59.12	13.91	4.30	1.43	0.20	2.45	0.20	0.20	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	33.80	7.20	4.69	1.56	1.56	1.25	0.00	0.00	0.31	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	29.95	5.65	2.54	2.26	0.00	0.28	0.85	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	39.66	5.53	6.46	2.77	0.00	1.84	0.00	0.00	0.92	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	42.07	9.90	0.00	7.42	0.00	0.00	2.47	0.00	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	45.26	8.12	5.42	3.09	0.77	1.16	0.77	0.39	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	54.55	4.81	6.42	4.81	0.00	1.60	0.00	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	73.03	15.65	5.22	5.22	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	42.96	7.49	5.21	1.63	0.98	1.95	1.63	0.33	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	42.83	9.06	9.88	2.06	0.82	1.65	0.00	0.41	1.65	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	69.98	10.00	3.33	6.66	0.00	0.00	0.00	3.33	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	49.78	8.11	5.59	2.24	0.84	0.28	0.28	0.00	0.00	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	43.80	7.52	9.15	2.29	1.31	0.98	0.65	0.00	0.98	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	64.59	11.74	6.71	2.52	0.00	0.84	0.84	0.00	0.84	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	61.07	10.50	6.04	2.86	0.95	1.59	0.64	0.32	0.00	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	44.84	6.11	7.81	3.06	1.36	0.34	0.00	0.34	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	50.12	16.71	2.09	2.09	2.09	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	63.57	14.32	4.58	5.15	0.57	2.29	0.00	0.57	1.15	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	48.25	11.25	4.74	2.37	0.89	2.37	0.30	0.00	0.59	1.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	55.91	13.55	5.08	1.69	3.39	3.39	1.69	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	56.75	11.18	7.46	3.31	2.07	1.66	0.00	0.00	0.41	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	55.69	12.43	5.75	4.37	1.38	1.38	0.46	0.46	0.23	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	73.76	21.07	15.81	10.54	0.00	0.00	0.00	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	46.51	8.84	8.46	8.07	1.15	1.54	0.38	0.38	0.38	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	44.98	9.13	4.24	1.96	0.65	1.63	0.98	0.00	0.98	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	66.88	15.38	5.35	5.35	2.01	3.34	0.67	0.00	0.67	4.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	79.37	17.72	6.93	2.31	0.77	1.54	0.00	0.00	3.08	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	72.23	14.38	8.56	5.48	2.40	4.11	1.71	0.34	2.74	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	109.33	24.85	4.97	0.00	0.00	2.48	0.00	2.48	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	73.61	21.71	7.55	3.77	0.47	1.89	0.47	0.00	0.47	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	80.26	19.31	6.03	2.41	1.81	0.60	0.00	0.00	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	94.61	30.01	8.65	4.07	3.05	1.53	0.51	1.02	1.02	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	67.00	18.75	5.98	3.19	1.60	3.19	0.00	0.00	1.20	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	74.00	22.20	8.39	5.43	2.96	1.97	0.99	0.00	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	95.62	17.71	8.26	5.90	1.18	0.00	0.00	0.00	3.54	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	67.10	16.34	5.25	4.08	2.33	1.75	0.00	0.00	1.75	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	70.22	21.94	4.83	1.32	1.32	2.19	0.44	0.00	0.44	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	56.80	17.80	3.39	1.70	1.70	0.85	1.70	0.00	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	58.50	6.57	7.76	2.98	2.98	0.60	1.19	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	49.01	12.13	4.85	2.91	2.91	0.00	0.49	0.00	0.49	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	41.09	6.85	6.85	7.99	1.14	2.28	1.14	1.14	2.28	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	32.85	12.47	7.48	2.08	0.83	0.83	0.83	0.00	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	52.85	12.37	6.75	5.62	1.12	0.00	1.12	0.00	0.00	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	8.25	2.22	2.85	0.32	0.00	0.63	0.00	0.00	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	6.68	1.25	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	13.00	2.20	1.62	1.28	0.00	0.58	0.23	0.12	0.00	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	13.67	2.36	2.53	1.86	0.51	0.51	0.34	0.34	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	13.88	1.82	4.32	0.91	1.14	0.23	0.91	0.00	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	13.12	2.62	4.37	1.31	0.87	0.33	0.11	0.11	0.00	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	12.25	3.65	2.79	1.72	0.64	0.21	0.21	0.00	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	11.84	3.23	2.37	0.65	0.65	0.43	0.43	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	11.71	2.37	1.49	1.25	0.50	0.25	0.00	0.12	0.00	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	9.95	1.37	1.89	0.69	0.51	0.17	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	7.69	2.56	3.20	1.60	0.32	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	43.09	6.16	7.28	1.68	0.00	0.56	0.56	0.00	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	68.38	8.66	10.39	1.73	1.73	2.16	0.00	0.43	0.87	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	2.64	5.29	2.64	2.64	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	46.56	10.58	8.47	4.59	1.41	2.12	0.71	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	42.86	14.53	6.54	3.63	0.00	5.09	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	14.69	4.37	2.45	1.05	0.52	0.00	0.35	0.00	0.00	0.00
Hepatocyte, donor1	11523-119I2	27.84	6.05	19.37	16.95	6.05	6.05	1.21	3.63	0.00	0.00
Hepatocyte, donor2	11603-120I1	46.33	8.62	34.47	38.78	5.39	10.77	7.54	16.16	0.00	2.15
Hepatocyte, donor3	11684-122I1	47.24	13.50	21.47	23.31	8.59	4.91	1.23	2.45	1.23	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	28.14	11.54	5.94	1.57	1.22	2.10	0.52	1.05	0.70	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	21.40	7.82	3.57	0.96	0.82	0.96	0.27	0.00	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	3.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	9.47	1.63	3.10	0.65	0.16	0.16	0.00	0.00	0.33	0.08
Keratinocyte - epidermal, donor2	11349-117G8	2.93	0.00	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	5.21	1.42	0.66	0.00	0.19	0.19	0.19	0.00	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	22.48	6.24	2.61	0.11	0.00	0.23	0.34	0.00	0.11	0.34
Keratocytes, donor1	11527-119I6	51.92	11.35	5.85	1.38	0.34	1.38	0.00	0.00	1.03	0.00
Keratocytes, donor2	11607-120I5	25.78	9.37	9.37	2.34	0.00	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	17.59	4.35	2.96	0.40	0.00	0.59	0.00	0.00	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	28.57	2.20	0.00	0.00	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	24.81	4.31	2.16	0.00	0.00	1.08	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	37.48	12.46	3.92	0.69	0.46	0.58	0.58	0.23	0.35	0.00
Lens Epithelial Cells, donor3	11690-122I7	19.98	5.25	5.15	1.01	0.20	1.11	0.20	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	12.57	3.08	2.02	0.24	0.12	0.12	0.12	0.00	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.14	0.84	1.67	0.28	0.28	0.84	0.28	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	10.86	3.46	2.68	0.63	0.00	0.31	0.00	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	10.22	0.54	2.15	0.54	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	6.93	1.58	1.26	0.00	0.00	0.63	0.32	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	9.92	2.80	1.73	0.11	0.11	0.43	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	11.08	0.82	2.46	0.41	0.00	0.41	0.00	0.00	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	8.34	2.28	2.78	0.25	0.00	0.51	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.99	1.69	2.11	0.00	0.14	0.56	0.28	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.12	2.37	1.58	0.00	0.00	0.00	0.40	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.56	2.52	1.55	0.58	0.00	0.39	0.00	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.81	1.85	1.11	0.00	0.19	0.37	0.00	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.41	1.39	3.48	0.35	0.00	0.70	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	9.54	1.43	3.58	0.48	0.00	0.95	0.00	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	10.03	3.16	2.33	0.14	0.00	0.27	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	11.39	1.85	2.16	0.31	0.00	0.31	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	6.23	0.94	0.62	0.00	0.00	0.62	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	10.98	2.74	2.20	0.37	0.00	0.18	0.18	0.00	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	11.19	2.96	2.30	0.66	0.33	0.00	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	12.01	0.59	2.34	0.59	0.00	0.88	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	10.70	4.23	1.00	0.00	0.00	0.25	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.76	2.91	1.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	7.54	0.54	0.54	0.27	0.00	0.27	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.99	3.18	1.67	0.00	0.15	0.15	0.15	0.00	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	8.81	0.00	1.56	1.04	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.75	1.05	1.47	0.21	0.00	0.00	0.00	0.00	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	11.58	3.01	2.11	0.15	0.15	0.60	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.69	0.69	0.69	0.00	0.00	0.00	0.00	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	7.15	1.51	1.13	0.19	0.00	0.38	0.00	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	12.51	3.71	2.44	0.21	0.11	0.42	0.00	0.00	0.11	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	10.18	2.91	1.94	0.00	0.00	0.00	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	8.27	0.33	0.99	0.33	0.00	0.33	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	11.52	2.35	1.24	0.12	0.25	0.99	0.12	0.00	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	10.37	2.96	0.37	0.74	0.00	0.00	0.00	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.92	0.74	0.74	0.49	0.00	0.74	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	11.00	2.89	0.69	0.14	0.00	0.41	0.00	0.00	0.14	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	9.01	3.22	0.96	0.32	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	8.22	1.22	3.04	0.61	0.30	0.30	0.30	0.00	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.94	1.82	1.54	0.14	0.14	0.14	0.00	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	8.18	2.13	1.78	0.36	0.00	0.36	0.00	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.30	1.45	0.97	0.00	0.00	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	11.83	3.58	0.93	0.16	0.16	0.31	0.00	0.16	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	11.46	3.94	0.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	6.53	2.61	1.96	0.65	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	10.83	4.00	2.35	0.00	0.00	0.47	0.24	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	14.48	4.70	2.23	0.12	0.00	0.62	0.12	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.38	2.56	0.51	0.26	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.95	2.39	1.79	0.30	0.00	0.90	0.00	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	0.00	0.00	0.00	0.00	2.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	17.64	6.14	2.30	0.00	0.00	0.00	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	18.56	2.97	1.48	0.00	0.00	0.00	0.74	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	10.16	4.65	3.39	0.42	0.00	0.42	0.00	0.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	11.96	1.41	1.41	0.70	0.00	0.00	0.00	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.94	1.87	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	13.40	2.58	0.00	1.03	0.00	1.55	0.00	0.52	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	7.14	0.00	2.38	1.19	0.00	1.19	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	8.14	2.04	1.36	1.58	0.23	0.68	0.90	0.68	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	12.51	1.45	1.45	1.45	0.00	0.00	0.29	0.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	12.15	2.70	1.80	0.45	0.45	0.00	1.35	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	14.36	4.47	1.90	0.68	0.14	0.68	0.41	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	13.35	3.59	2.05	0.51	0.00	0.00	0.51	1.03	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	15.88	3.53	2.47	1.06	0.00	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	13.33	0.00	2.67	0.67	1.33	0.00	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	16.30	0.00	1.53	0.51	0.00	0.51	2.55	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	15.47	2.40	2.13	0.00	0.80	0.53	0.27	0.00	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	12.09	4.35	2.08	0.57	0.00	0.57	0.76	0.00	0.19	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	15.34	3.07	1.84	0.61	0.00	0.00	1.84	0.00	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.05	0.82	1.63	3.26	0.00	0.82	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	11.25	2.08	1.25	0.42	0.21	0.00	0.00	0.42	0.21	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	11.49	1.96	2.24	0.00	0.28	0.00	0.28	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	20.61	3.09	0.00	0.00	0.00	1.03	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	13.35	2.32	1.45	0.87	0.00	0.00	0.00	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	13.45	1.49	1.49	0.60	0.00	0.30	1.20	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	9.41	2.77	1.11	0.00	0.00	0.55	0.55	0.00	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	18.73	2.83	4.24	1.06	0.71	0.35	1.41	0.71	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	19.91	3.69	2.58	0.37	0.00	0.74	0.00	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	14.97	2.30	2.30	0.00	0.00	2.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	14.97	1.54	1.15	0.00	0.00	0.38	0.38	0.00	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	13.02	1.70	1.13	0.57	0.00	0.00	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	17.23	3.28	3.28	1.64	0.82	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	19.88	4.52	0.90	0.00	0.00	0.90	0.45	0.45	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.24	1.44	1.44	0.00	0.00	0.00	0.72	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	12.70	2.24	3.73	0.00	0.00	0.75	0.75	0.00	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	15.24	2.60	1.49	0.37	0.00	0.37	1.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	9.48	3.02	2.58	0.43	0.00	0.86	0.00	0.00	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.99	0.86	2.57	0.86	0.86	0.00	0.86	0.86	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	11.33	3.33	2.67	0.00	0.00	0.33	0.00	0.67	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	9.65	2.41	1.21	0.60	0.60	0.00	0.00	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	15.64	4.98	1.42	0.00	0.00	0.00	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	12.03	3.44	1.37	0.00	0.34	0.69	0.69	0.69	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	13.42	4.83	1.07	2.15	0.00	0.00	0.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	17.51	4.04	2.02	0.00	0.67	0.00	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	18.89	2.96	3.70	0.74	0.00	0.74	0.00	0.37	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	11.63	4.65	0.00	0.00	0.00	1.16	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	14.81	3.17	3.17	0.00	0.00	1.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	14.01	2.40	4.00	0.40	0.40	0.40	0.40	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	14.54	2.91	0.00	2.18	0.00	0.00	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	20.70	3.83	3.83	0.00	0.00	0.77	1.53	1.53	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	17.76	3.45	1.48	2.47	0.49	0.49	0.49	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	14.11	0.94	1.88	0.00	0.00	0.00	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	14.08	5.53	4.02	0.50	0.50	0.00	1.51	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	19.38	2.70	7.66	0.45	0.00	0.45	0.90	0.45	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	20.65	1.72	0.00	0.00	0.00	0.00	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	14.25	4.01	3.56	0.45	0.45	0.45	0.89	0.89	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	16.81	1.96	2.35	2.35	0.00	0.39	0.78	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	11.22	0.00	1.98	1.98	0.66	0.00	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	17.64	3.11	1.56	0.52	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	18.82	3.94	4.38	1.31	0.00	0.44	0.00	0.00	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	13.98	2.24	2.24	0.00	0.00	1.68	0.56	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	16.78	3.53	0.44	1.32	0.44	0.44	1.77	0.44	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	14.66	3.47	1.93	0.39	0.00	0.39	0.39	0.39	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	12.66	2.53	2.53	0.51	0.00	0.51	0.51	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	16.82	2.40	1.44	0.96	0.00	0.00	0.96	0.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	19.48	3.18	2.78	0.00	0.00	1.19	0.80	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	17.62	2.43	3.04	1.82	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	13.83	2.08	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	17.86	2.28	1.52	0.00	0.38	0.76	1.14	0.38	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	17.56	2.07	3.10	0.52	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	15.72	1.81	1.81	0.60	0.00	0.60	0.60	0.00	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	16.48	3.17	3.17	0.32	0.32	1.27	0.63	0.00	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	18.13	1.60	2.67	1.07	0.00	0.00	0.53	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	28.73	1.15	4.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	16.97	4.63	3.09	0.51	0.00	0.00	1.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.27	4.24	2.12	0.71	0.00	2.12	0.00	0.00	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	13.62	1.70	6.24	2.27	0.00	0.00	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	18.31	2.50	1.66	0.42	0.00	0.42	0.42	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	12.53	0.78	1.57	0.00	0.78	1.57	0.00	1.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	21.29	2.09	2.92	0.42	0.00	0.00	0.42	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	13.47	5.58	0.46	0.93	0.00	0.00	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	10.70	2.68	2.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	15.50	2.67	2.14	0.00	0.00	0.00	1.60	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	11.31	1.62	2.02	0.00	0.00	0.40	0.40	0.00	0.00	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	23.86	0.92	0.92	0.00	0.00	0.00	0.00	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	23.12	0.00	3.56	1.78	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	18.81	2.85	2.28	0.00	0.00	0.00	0.57	1.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.10	2.30	1.53	0.00	0.00	1.53	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	23.53	3.83	1.09	1.09	0.00	0.00	0.55	0.55	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	18.26	6.24	1.34	0.89	0.00	0.45	0.45	0.45	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	10.66	2.34	1.30	0.00	0.00	0.26	0.78	1.30	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	22.55	1.99	2.65	2.65	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	29.10	2.08	2.08	2.08	0.00	0.00	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	1.37	0.23	0.68	0.00	0.00	0.00	0.46	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	1.65	1.65	0.92	0.00	0.00	0.18	1.10	0.55	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	3.93	1.84	0.79	0.13	0.13	0.13	0.66	0.79	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	1.74	0.63	0.48	0.00	0.00	0.00	0.00	0.16	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	8.27	1.49	1.59	0.50	0.10	0.10	0.10	0.00	0.00	0.10
Mammary Epithelial Cell, donor2	11350-117G9	8.40	4.63	0.58	0.58	0.00	0.29	0.00	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	14.72	2.24	2.49	0.25	0.00	0.50	0.00	0.00	0.25	0.25
Mast cell - stimulated, donor1	11487-119E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	0.97	0.00	0.00	0.00	0.00	0.00	0.00	0.11	0.00	0.11
Mast cell, donor2	11565-120D8	24.37	4.75	6.54	0.89	0.00	0.59	14.86	1.49	0.89	1.19
Mast cell, donor3	11566-120D9	18.01	4.73	4.95	0.90	0.23	0.23	11.03	2.25	0.90	0.90
Mast cell, donor4	11567-120E1	21.63	5.14	4.79	0.53	0.00	0.35	14.36	3.90	0.89	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	1.89	0.33	0.22	0.00	0.00	0.00	0.11	0.44	0.00	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	1.17	0.00	0.00	0.00	0.00	0.00	0.58	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	4.02	0.34	0.80	0.23	0.00	0.00	1.49	0.23	0.11	0.23
Mast cell, expanded, donor8	11941-126A6	2.18	0.17	0.17	0.17	0.00	0.17	0.84	0.17	0.00	0.17
Melanocyte - dark, donor1	11502-119F8	11.64	3.78	1.99	0.10	0.40	0.30	0.20	0.00	0.00	0.10
Melanocyte - dark, donor2	11582-120F7	13.15	2.08	0.69	0.35	0.35	0.00	0.35	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	43.90	10.50	7.82	1.16	0.36	0.94	1.16	0.43	0.43	0.07
Melanocyte - light, donor1	11274-116H5	36.44	10.11	4.47	2.12	0.24	1.18	0.71	0.00	2.35	0.71
Melanocyte - light, donor2	11351-117H1	47.09	10.92	6.14	0.68	0.00	2.73	0.00	0.00	2.73	0.00
Melanocyte - light, donor3	11423-118G1	24.28	6.07	6.94	0.00	0.00	0.00	0.00	0.87	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	38.11	11.56	3.54	0.83	0.10	0.10	1.04	0.73	0.52	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	51.91	7.53	4.57	1.08	0.00	0.81	1.34	1.08	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	70.45	18.21	6.70	2.41	0.27	2.41	1.87	0.54	1.34	0.27
Meningeal Cells, donor1	11493-119E8	74.44	13.65	8.81	2.48	0.12	1.49	0.50	0.25	0.37	0.12
Meningeal Cells, donor2	11573-120E7	83.63	16.73	7.92	2.20	2.64	3.08	1.32	0.00	0.44	0.44
Meningeal Cells, donor3	11654-122E7	27.96	5.79	4.48	1.14	0.08	0.73	0.00	0.08	0.00	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	15.11	4.85	2.00	0.29	0.00	0.57	0.00	0.29	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	21.33	7.35	7.04	3.62	1.31	1.51	0.20	0.20	0.30	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	22.34	11.83	3.94	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	20.93	2.62	3.92	1.31	1.31	0.00	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	17.94	3.59	2.15	2.15	0.00	0.72	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	56.75	20.12	11.65	11.86	5.72	4.87	2.33	1.06	1.27	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	65.34	17.09	10.56	14.07	10.56	2.01	0.50	2.51	0.50	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	31.86	7.91	2.86	1.54	0.00	1.10	0.66	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	30.68	6.58	3.65	0.00	0.73	0.00	1.46	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	27.62	7.16	5.12	1.84	0.20	0.20	0.20	0.00	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	21.33	6.51	4.02	0.97	0.14	0.69	0.28	0.14	0.14	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	29.74	8.55	5.58	2.60	0.00	1.49	0.37	0.00	0.74	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	26.71	10.00	3.42	2.50	0.66	0.66	0.13	0.13	0.66	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	18.69	5.93	3.26	1.48	0.30	1.48	0.00	0.59	0.59	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	44.38	2.34	7.01	0.00	0.00	4.67	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	37.78	12.17	6.40	4.48	1.28	0.64	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	14.89	4.96	5.32	0.35	0.00	0.71	0.35	0.00	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	19.70	10.63	4.07	0.94	0.63	1.25	0.00	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	15.24	5.08	4.35	0.73	0.00	0.73	0.00	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	10.34	2.92	1.06	0.53	0.00	1.33	0.00	0.00	0.80	0.00
Mesothelial Cells, donor2	12156-128G5	13.01	3.00	1.50	1.00	1.50	0.00	0.00	0.00	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	17.99	5.78	3.54	1.01	0.36	0.58	0.14	0.14	0.22	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	14.85	0.00	5.40	1.35	0.00	1.35	5.40	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	29.06	4.93	2.71	2.22	0.25	0.99	4.43	3.45	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	26.80	4.12	3.24	1.18	0.29	0.29	6.18	4.42	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	3.46	0.00	0.00	0.00	0.00	6.91	6.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	16.74	4.96	3.41	0.62	0.00	0.00	4.65	2.17	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	20.54	4.36	2.07	1.87	0.41	0.21	2.07	2.49	0.41	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	2.32	0.00	0.00	0.00	0.00	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	21.02	2.25	4.00	0.75	0.25	0.00	4.50	1.50	0.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	25.14	3.72	4.19	2.33	0.93	1.86	7.91	3.26	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	16.26	4.27	2.24	0.41	0.20	0.20	4.27	1.22	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	23.76	3.56	4.75	1.58	0.40	0.79	3.17	1.98	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	11.50	6.19	3.54	3.54	0.00	0.00	2.65	2.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	16.34	1.90	2.28	0.38	0.00	0.38	3.80	0.76	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	15.79	0.00	1.32	0.00	0.00	0.00	1.32	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	13.37	2.12	3.40	1.06	0.21	0.85	3.82	2.33	0.42	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	28.55	0.92	0.92	0.92	0.00	0.00	1.84	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	18.18	3.87	1.79	1.19	0.00	0.00	6.26	2.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	23.47	1.68	1.68	0.00	0.00	1.68	5.03	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	13.30	2.76	1.25	0.75	0.00	0.25	2.01	0.75	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	19.25	5.47	2.61	0.48	0.48	0.71	4.04	2.38	0.00	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.85	0.55	0.00	0.00	0.00	0.00	2.21	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	15.89	2.30	0.92	0.69	0.23	0.23	2.53	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	18.09	4.21	1.68	0.84	0.21	0.42	4.00	4.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	6.52	1.02	1.43	0.61	0.00	0.20	1.83	0.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	13.95	2.57	2.15	0.86	0.21	0.86	3.00	2.15	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	25.56	3.33	3.33	1.33	0.22	0.44	3.33	2.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	11.17	1.97	0.88	0.22	0.22	0.44	3.29	0.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	19.77	1.01	2.03	0.51	0.00	0.51	5.07	2.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	0.00	0.00	0.00	0.00	0.00	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	16.58	1.90	0.82	0.27	0.27	0.54	2.17	1.63	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	17.64	0.88	2.94	0.29	0.00	0.29	3.23	1.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	1.09	0.00	0.00	0.00	0.00	2.18	3.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	13.46	1.92	1.44	0.96	0.00	0.48	0.96	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	15.21	2.00	2.00	1.20	0.00	0.00	3.20	1.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	10.97	0.00	0.00	0.00	0.00	0.00	0.00	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	10.01	1.50	1.50	0.00	0.00	1.50	1.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	0.00	0.00	0.00	0.00	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	9.63	2.19	0.44	1.31	0.44	0.00	0.00	1.31	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	28.69	2.21	2.21	1.10	0.00	0.00	1.10	4.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.68	0.64	0.64	0.00	0.00	0.00	1.28	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	7.93	2.98	1.49	0.74	0.00	0.00	1.49	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	23.66	1.39	2.09	2.09	0.00	0.00	4.18	2.78	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	0.00	0.00	0.00	0.00	0.00	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.47	2.05	0.34	0.68	0.00	0.34	1.37	0.34	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	12.25	3.06	1.75	0.44	0.44	0.00	1.75	1.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	3.20	0.71	1.42	0.00	0.00	0.00	0.36	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	6.73	0.56	1.68	0.56	0.00	0.00	2.52	0.84	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	14.55	1.25	2.08	0.83	0.00	0.42	2.08	2.49	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.83	1.75	1.17	0.58	0.00	0.00	1.17	1.17	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	10.26	3.02	0.90	0.30	0.00	0.00	1.21	1.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7.51	2.50	2.92	0.00	0.00	0.00	3.34	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	10.16	2.77	0.92	0.00	0.00	1.85	1.85	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	11.38	2.85	4.55	2.85	0.57	0.00	2.85	1.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	3.18	0.28	0.83	0.41	0.00	0.14	0.28	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	4.41	0.52	0.26	0.78	0.00	0.00	1.55	1.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.44	3.43	2.57	0.86	0.00	0.43	2.57	2.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.81	1.91	0.64	1.27	0.00	0.00	2.54	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	5.60	0.80	1.07	0.80	0.00	0.27	1.87	0.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	16.16	1.80	2.10	0.60	0.30	0.30	1.80	1.50	0.30	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	4.80	1.13	0.71	0.71	0.14	0.00	1.55	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	4.14	0.64	1.27	0.00	0.00	0.00	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	13.71	2.43	3.10	1.77	0.00	0.22	2.43	1.77	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	4.17	1.14	1.52	0.38	0.00	0.38	1.14	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	5.40	1.99	1.70	0.85	0.00	0.28	1.70	1.99	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	7.37	1.23	1.47	1.97	0.25	0.00	2.70	0.98	0.00	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	4.56	1.30	0.00	0.00	0.00	0.00	2.61	1.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	5.88	0.88	1.47	0.88	0.00	0.59	0.88	0.88	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	9.51	2.59	1.44	1.15	0.00	0.00	2.02	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	5.36	0.00	1.24	0.41	0.00	0.00	1.24	1.24	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	4.76	0.89	0.60	0.89	0.00	0.89	0.60	0.30	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	0.00	0.00	1.78	0.00	0.00	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	3.61	0.66	0.00	0.00	0.00	0.00	0.33	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	1.05	0.00	0.00	0.00	0.00	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	8.90	0.79	1.38	0.40	0.00	0.20	3.16	0.79	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	23.28	4.66	2.79	0.00	0.00	0.93	0.93	3.73	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	3.00	1.50	0.38	0.00	0.00	0.00	0.75	0.75	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	9.59	2.40	0.27	0.00	0.00	0.00	1.33	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	1.47	0.34	0.23	0.00	0.00	0.00	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.16	0.74	0.74	0.74	0.00	0.00	0.74	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	1.83	0.37	1.10	0.00	0.00	0.00	1.47	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	0.00	0.00	0.00	0.00	0.00	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1.60	0.00	0.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	6.06	0.00	1.01	0.00	0.00	0.00	0.00	1.01	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	1.26	1.26	0.00	0.00	0.00	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	0.00	3.26	0.00	0.00	9.79	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	0.00	0.00	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	26.07	9.48	4.31	4.52	0.43	1.29	0.86	0.22	0.65	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	72.12	17.25	6.79	9.41	1.57	2.61	3.14	4.18	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	46.72	4.67	2.67	3.34	0.00	0.67	1.33	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	64.69	6.26	6.26	4.17	0.83	0.42	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	77.96	11.60	8.37	7.04	1.14	0.19	0.38	0.00	0.57	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	110.11	4.79	9.58	4.79	0.00	0.00	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	35.36	6.12	2.72	1.36	0.68	0.00	0.00	0.00	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	38.59	18.38	7.35	0.00	1.84	1.84	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	40.60	7.12	5.86	0.42	0.00	0.84	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	54.39	9.76	3.72	2.32	0.46	0.46	0.70	1.16	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	64.85	7.30	6.49	3.24	0.27	0.27	0.27	0.00	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	42.68	8.20	3.78	2.31	1.05	0.42	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	28.79	6.95	4.47	2.98	0.00	0.00	0.00	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	34.92	7.85	4.06	2.71	0.27	0.27	0.00	0.00	0.81	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	27.20	5.21	2.49	0.68	0.45	0.23	0.00	0.00	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	55.69	7.35	4.90	2.78	0.16	0.49	0.16	0.16	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	31.17	4.01	5.47	1.28	0.00	0.36	0.18	0.00	0.18	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	29.70	8.49	2.65	2.12	0.00	1.06	0.53	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	37.22	5.40	4.80	1.20	0.60	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	46.27	12.80	6.56	2.30	0.33	1.64	0.33	0.00	0.00	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	42.12	6.50	1.79	0.98	0.65	0.33	0.65	0.00	0.16	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	39.33	3.70	7.06	1.76	0.88	0.88	0.00	0.00	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	30.94	4.22	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	37.70	7.36	3.22	1.38	0.00	0.46	0.00	0.00	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	31.81	7.07	5.46	2.89	0.64	0.32	0.00	0.00	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	37.59	8.97	6.55	2.07	0.34	0.34	0.00	0.00	0.34	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	63.21	22.76	5.06	0.00	2.53	5.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	27.85	4.90	3.56	2.23	0.67	0.67	0.22	0.22	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	37.68	5.50	3.39	2.54	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	40.82	7.60	2.61	1.90	0.95	0.47	0.24	0.00	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	19.75	7.30	4.72	2.15	0.86	0.43	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	34.99	5.33	4.67	1.67	1.00	0.33	0.00	0.00	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	42.83	7.21	4.96	0.90	0.45	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	17.86	1.59	3.17	2.78	0.79	0.40	0.40	0.00	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	26.00	4.64	3.71	3.71	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	22.70	6.05	2.27	1.14	0.00	0.00	0.38	0.00	0.00	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	38.78	6.84	2.61	0.98	0.65	0.00	0.00	0.33	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	40.96	9.59	4.79	2.18	1.31	0.87	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	43.87	4.52	5.43	0.45	0.45	0.45	0.00	0.00	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	24.69	3.53	3.53	0.00	0.00	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	20.61	2.66	1.99	0.00	0.66	1.33	0.00	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	27.78	3.47	3.47	2.48	0.50	0.50	0.00	0.00	0.00	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	31.77	6.13	2.68	2.30	0.00	0.38	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	26.31	6.65	4.54	1.51	0.60	0.30	0.00	0.00	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	26.30	2.87	3.09	1.99	0.88	0.88	0.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	18.30	8.13	4.74	2.71	0.68	0.68	0.00	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	15.33	0.00	5.11	0.00	5.11	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	23.78	4.88	3.66	1.83	0.00	0.00	0.00	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	26.44	5.04	4.41	2.20	0.00	0.63	0.00	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	59.32	9.38	2.12	0.30	0.30	0.30	0.00	0.30	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	29.27	2.37	2.37	0.00	0.00	0.00	0.00	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	48.75	6.80	1.13	5.67	0.00	1.13	0.00	0.00	0.00	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	5.06	5.06	0.00	0.00	0.00	0.00	0.00	10.12	0.00
Myoblast, donor1	11241-116D8	5.71	1.99	1.74	1.37	0.62	0.50	0.12	0.00	0.00	0.12
Myoblast, donor2	11322-117D8	12.66	1.73	3.26	0.77	0.00	0.19	0.19	0.19	0.00	0.19
Myoblast, donor3	11398-118D3	10.93	3.87	3.70	2.19	0.34	0.00	0.17	0.17	0.34	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	0.74	0.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neural stem cells, donor1	11275-116H6	59.52	11.61	17.06	6.53	2.18	3.27	10.89	1.45	1.45	0.73
Neural stem cells, donor2	11352-117H2	67.40	21.18	7.70	0.00	0.00	5.78	15.41	0.00	0.00	1.93
Neurons, donor1	11494-119E9	43.24	6.83	3.41	3.41	0.00	1.14	2.28	0.00	1.14	0.00
Neurons, donor2	11574-120E8	42.05	6.83	5.94	1.32	0.00	2.20	2.86	1.32	0.88	0.00
Neurons, donor3	11655-122E8	55.91	9.87	4.93	3.29	0.00	2.47	2.47	0.82	1.64	0.82
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	13.54	5.94	5.34	0.71	0.24	0.24	0.12	0.00	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	14.65	3.91	3.91	0.00	0.00	1.30	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	13.84	3.21	3.61	0.40	0.00	0.40	0.00	0.00	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	31.38	5.92	3.85	1.93	0.41	0.41	0.28	0.14	0.14	0.28
Olfactory epithelial cells, donor2	11934-125I8	26.05	5.93	5.79	3.04	1.45	0.29	0.14	0.14	0.43	0.14
Olfactory epithelial cells, donor3	11935-125I9	19.98	2.04	3.75	1.36	0.45	0.68	0.23	0.00	0.11	0.11
Olfactory epithelial cells, donor4	11936-126A1	20.36	3.70	3.02	1.07	0.19	0.78	0.00	0.10	0.19	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	34.91	11.43	4.81	0.00	3.01	1.20	1.20	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	30.20	7.44	4.25	1.70	0.43	1.06	0.85	0.64	1.28	0.64
Osteoblast - differentiated, donor2	11353-117H3	17.15	2.29	3.43	0.00	0.00	1.14	0.00	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	11.79	3.72	2.48	1.24	0.62	0.00	1.24	0.00	0.62	0.62
Osteoblast, donor1	11277-116H8	27.75	6.64	4.30	4.30	1.17	1.37	0.39	0.00	0.98	0.20
Osteoblast, donor2	11354-117H4	33.01	9.13	8.43	5.62	0.00	0.70	1.40	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	53.50	17.06	8.53	1.78	2.31	1.96	0.71	0.36	0.71	0.18
Pancreatic stromal cells, donor1	11249-116E7	29.74	11.37	7.67	4.63	1.85	1.85	0.59	0.34	1.35	1.43
Pericytes, donor1	11491-119E6	57.19	12.46	7.90	6.45	1.45	3.45	0.22	0.11	0.67	0.56
Pericytes, donor2	11571-120E5	57.04	9.28	7.70	3.17	0.45	1.36	0.23	0.00	0.68	0.00
Pericytes, donor3	11652-122E5	41.91	8.95	3.87	1.22	0.41	2.03	0.41	0.20	0.81	0.41
Perineurial Cells, donor1	11499-119F5	24.30	8.70	3.50	1.02	0.11	0.68	0.23	0.11	0.11	0.00
Perineurial Cells, donor2	11579-120F4	13.34	5.15	2.67	0.64	0.37	0.46	0.18	0.00	0.18	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	3.83	0.96	0.24	0.72	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	15.52	2.22	3.33	0.00	0.00	1.11	0.00	0.00	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	16.30	3.73	1.77	0.59	0.20	0.59	0.00	0.00	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	18.99	4.43	0.95	1.58	0.00	0.63	0.32	0.32	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	12.19	3.00	2.81	1.13	0.38	0.75	0.19	0.00	0.00	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	9.14	2.35	3.92	2.48	1.70	0.91	1.04	0.26	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	16.66	3.83	2.03	2.25	0.90	0.90	0.00	0.23	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	14.07	3.09	2.77	1.60	0.43	0.53	0.11	0.11	0.43	0.43
Preadipocyte - omental, donor2	11329-117E6	24.88	8.29	3.93	4.36	1.75	1.75	0.00	0.00	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	21.92	10.03	3.58	2.58	1.29	1.29	0.29	0.43	0.29	0.43
Preadipocyte - perirenal, donor1	11469-119C2	5.91	1.97	0.98	0.98	0.98	1.97	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	25.49	9.83	16.89	8.91	1.54	2.15	0.31	0.61	0.61	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	36.12	7.44	11.33	2.66	0.18	0.89	1.06	0.18	0.18	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	21.46	7.32	3.92	2.72	0.00	1.02	0.00	0.17	0.51	1.36
Preadipocyte - visceral, donor1	11280-116I2	24.13	4.94	7.17	3.45	0.75	1.40	0.65	0.00	0.47	0.47
Preadipocyte - visceral, donor2	11357-117H7	18.41	3.22	5.98	2.76	0.46	0.00	0.00	0.00	0.46	1.38
Preadipocyte - visceral, donor3	11429-118G7	28.11	5.02	7.21	4.60	1.04	1.46	0.31	0.21	0.84	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	33.19	14.63	5.13	1.66	1.51	1.66	1.36	0.45	1.21	2.72
Prostate Epithelial Cells, donor2	11331-117E8	15.57	2.84	3.39	1.35	0.54	0.41	0.14	0.14	1.08	0.54
Prostate Epithelial Cells, donor3	11404-118D9	15.55	5.39	0.67	0.06	0.06	0.24	0.00	0.00	1.04	0.67
Prostate Stromal Cells, donor1	11254-116F3	25.97	11.96	6.72	7.63	1.48	2.28	0.80	0.68	0.68	0.46
Prostate Stromal Cells, donor2	11332-117E9	38.01	9.68	7.35	4.48	2.69	2.69	1.43	0.18	0.72	1.08
Prostate Stromal Cells, donor3	11405-118E1	23.57	7.30	4.07	2.50	0.94	1.67	0.21	0.10	0.73	0.94
Renal Cortical Epithelial Cells, donor1	11516-119H4	99.64	30.66	8.39	2.19	2.55	3.65	1.46	0.36	1.09	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	77.01	23.22	7.28	2.36	1.11	2.70	1.46	0.55	0.69	0.49
Renal Epithelial Cells, donor1	11517-119H5	123.76	32.46	9.13	5.58	2.03	3.55	3.55	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	121.64	10.67	15.65	7.11	4.98	3.56	2.85	1.42	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	86.91	15.99	12.49	4.13	0.64	4.55	2.12	0.53	0.53	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	26.55	12.94	5.45	2.72	0.00	0.00	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	37.46	9.30	5.66	1.75	0.27	0.81	0.13	0.13	0.54	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	53.06	7.77	7.33	1.78	1.11	1.33	0.44	0.44	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	35.93	4.66	5.99	0.67	0.00	1.33	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	61.18	16.51	10.78	5.50	0.88	2.42	2.86	0.66	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	96.56	11.91	18.18	6.27	1.25	3.13	3.76	2.51	1.25	0.63
Renal Mesangial Cells, donor3	11679-122H5	85.72	18.59	7.49	6.10	1.11	1.39	1.94	1.11	0.28	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	87.77	22.28	6.98	2.95	1.34	2.95	2.15	1.07	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	73.37	16.45	4.64	2.53	1.69	0.84	2.11	0.42	1.27	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	106.45	20.44	10.22	5.98	2.51	2.31	2.70	0.77	0.58	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	19.45	5.44	1.30	0.00	0.78	0.52	0.26	0.00	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	23.88	4.83	4.26	0.28	0.57	1.42	0.57	0.28	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	26.76	8.23	3.09	0.00	0.00	0.00	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	10.29	3.51	1.51	0.00	0.00	0.25	0.25	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	26.06	7.75	9.09	3.07	1.87	3.34	2.41	1.60	0.80	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	68.79	4.47	2.68	0.00	0.00	0.00	7.15	0.89	0.00	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	20.36	3.85	2.75	1.65	0.00	0.55	8.26	1.10	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	38.86	5.22	5.22	1.74	0.58	1.74	5.80	0.58	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	34.85	4.94	5.85	2.60	0.39	0.39	1.56	0.52	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	44.59	6.85	4.87	1.29	0.70	0.60	2.48	0.40	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	32.01	7.81	4.80	1.67	0.67	0.67	2.12	0.78	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	39.07	8.43	2.36	2.23	0.25	0.87	2.60	0.00	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	40.32	6.18	3.96	1.05	0.00	0.70	2.21	0.35	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	39.06	8.09	6.47	1.85	0.00	0.69	0.92	0.69	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	55.58	3.15	6.30	1.92	0.27	0.82	2.19	0.82	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	34.79	6.05	3.78	1.82	0.00	1.36	2.72	0.45	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	33.33	7.17	3.40	1.97	0.36	0.54	2.87	0.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	46.77	5.45	4.73	2.01	0.43	0.57	1.00	0.57	0.43	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	39.71	6.22	3.76	1.50	0.11	0.97	1.50	0.54	0.21	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	34.52	7.08	4.65	2.43	0.00	0.66	3.10	0.44	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	53.91	3.82	6.50	2.68	0.38	0.76	2.87	1.34	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	44.90	8.01	4.10	1.58	0.28	0.84	2.24	0.37	0.37	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	33.26	7.33	6.76	1.50	0.19	1.50	2.07	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	71.79	5.44	8.10	1.46	0.53	1.73	3.45	0.66	0.80	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	37.18	8.96	3.60	2.63	0.58	1.17	1.56	0.10	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	29.60	7.83	5.16	1.15	0.38	1.72	2.29	0.95	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	51.15	4.27	4.59	2.67	0.53	1.39	1.60	0.96	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	44.85	10.09	4.48	1.68	0.56	1.12	1.96	0.84	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	37.26	6.15	5.30	1.20	0.17	0.51	1.88	0.85	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	48.86	4.92	6.02	1.82	0.73	0.91	2.73	0.55	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	41.20	8.22	3.43	1.35	0.25	0.86	1.59	0.61	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	35.19	9.13	4.57	1.88	0.27	0.54	2.69	0.27	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	48.83	2.59	5.43	0.94	0.24	1.18	2.36	1.42	0.00	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	45.64	5.56	1.98	0.60	0.20	0.99	2.98	0.79	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	37.18	7.02	5.85	0.94	0.47	0.23	3.74	0.94	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	48.11	3.53	4.15	1.45	0.00	0.62	2.49	0.83	0.62	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	43.80	6.42	3.54	0.44	0.22	0.22	1.77	0.00	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	35.30	8.36	4.80	1.67	0.21	0.63	2.30	0.00	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	47.91	3.90	4.85	1.35	0.40	0.81	2.42	1.21	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	37.98	6.30	5.45	1.02	0.51	0.68	2.38	0.85	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	35.09	6.94	3.28	2.31	0.39	0.77	3.86	1.74	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	41.95	2.41	4.81	1.89	0.69	0.69	2.24	0.86	0.17	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	42.93	6.72	4.80	0.82	0.27	0.55	1.92	0.69	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	26.27	6.57	5.91	2.46	0.16	1.15	2.13	0.33	0.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	55.56	5.79	5.62	2.22	0.51	1.02	2.90	1.19	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	32.25	9.03	3.26	0.74	0.15	0.44	2.07	0.44	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	39.45	5.60	4.00	1.60	0.27	0.53	1.60	1.07	0.27	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	59.45	7.74	5.25	1.38	0.28	1.11	6.08	1.52	0.83	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	33.10	8.10	1.90	0.48	0.24	1.19	2.14	1.90	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	47.97	10.68	5.24	3.22	0.60	1.61	5.04	1.41	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	41.34	4.52	3.58	1.22	0.66	0.38	3.48	0.85	0.47	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	40.53	9.43	6.29	1.05	0.35	1.40	8.38	2.45	0.00	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	41.71	6.35	4.23	0.91	1.51	1.51	9.37	5.14	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	36.23	4.04	3.55	1.59	0.61	0.61	6.12	1.71	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	59.82	12.37	8.88	2.33	1.02	1.89	19.65	3.64	1.31	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	43.81	10.34	5.48	0.61	0.00	1.83	7.30	1.83	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	50.94	3.32	4.22	1.51	0.90	0.60	5.12	2.11	0.60	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	41.62	5.88	4.52	1.36	0.68	1.13	7.69	3.62	0.90	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	50.02	9.88	5.99	1.20	0.30	0.90	9.29	2.40	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	44.63	5.67	4.49	1.30	0.59	1.06	6.38	2.72	2.13	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	49.31	8.75	2.99	0.85	0.85	1.49	10.25	2.77	1.71	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	60.10	7.21	1.80	1.20	0.00	1.80	6.61	2.40	0.60	4.81
Schwann Cells, donor1	11498-119F4	64.70	13.54	5.45	1.88	0.38	0.94	0.38	0.19	0.38	0.19
Schwann Cells, donor2	11578-120F3	27.22	10.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	39.65	10.73	6.13	2.19	0.44	1.97	0.00	0.22	0.22	0.00
Sebocyte, donor1	11220-116B5	25.20	15.34	6.57	1.64	0.55	1.64	0.00	0.00	0.00	0.55
Sebocyte, donor2	11301-117B5	20.22	6.89	2.30	0.92	0.00	0.46	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	12.16	3.71	3.30	0.21	0.21	0.82	0.00	0.00	0.00	0.41
Sertoli Cells, donor1	11255-116F4	53.01	11.60	4.97	11.60	1.66	3.31	0.00	0.00	1.66	1.66
Sertoli Cells, donor2	11333-117F1	45.19	5.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	29.82	8.45	2.73	0.18	0.18	0.53	0.09	0.09	0.79	0.88
Skeletal Muscle Cells, donor2	11358-117H8	18.07	2.17	4.34	0.72	0.00	0.72	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	68.56	10.87	5.85	4.18	0.00	0.84	0.00	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	17.44	3.46	2.51	1.26	0.31	0.47	0.16	0.16	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	21.70	4.76	3.86	0.45	0.15	0.45	0.15	0.00	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	38.32	5.85	4.62	2.31	0.31	0.62	0.15	0.15	0.46	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	21.42	6.30	6.05	0.63	0.13	0.38	0.25	0.13	0.76	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	32.39	6.14	4.57	1.71	0.57	0.00	0.14	0.00	0.00	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	24.50	6.94	5.36	1.39	0.60	0.79	0.20	0.20	0.30	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	22.92	6.40	4.89	1.26	0.25	0.84	0.00	0.00	0.17	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	39.81	14.48	5.07	2.17	0.00	0.72	0.00	0.00	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	27.11	2.75	3.58	1.79	0.83	1.24	0.28	0.00	0.00	0.14
Skin - palm, donor1	10286-104F7	32.23	2.69	2.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	15.71	1.73	2.16	0.72	0.14	0.29	0.00	0.14	0.29	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	111.23	9.00	24.54	13.90	0.00	0.82	0.82	0.00	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	17.40	2.47	1.82	0.91	0.13	0.00	0.13	0.00	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	13.48	3.75	1.81	0.70	0.14	0.28	0.14	0.00	0.56	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	31.51	5.91	2.11	0.56	0.14	0.42	0.70	0.14	0.84	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	42.08	12.48	12.69	2.33	1.27	2.75	0.85	0.42	0.42	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	28.78	8.24	1.50	0.52	0.30	0.75	0.15	0.00	0.60	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	34.56	3.09	3.70	1.23	1.23	1.23	0.31	0.00	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	12.23	1.33	7.11	2.89	0.44	0.22	0.44	0.00	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	11.17	4.11	3.53	1.18	0.59	0.00	1.18	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	11.05	0.66	2.87	1.10	0.00	0.44	0.22	0.00	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	13.39	6.69	7.09	3.54	0.79	0.79	0.39	0.00	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	23.18	6.18	0.77	2.32	0.00	0.00	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	25.02	8.01	4.00	2.00	1.00	1.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	9.58	2.13	2.00	1.20	0.13	0.93	0.27	0.00	0.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	17.29	6.21	3.32	2.66	0.89	3.10	0.66	0.00	0.22	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	12.93	1.54	1.28	1.02	0.90	0.38	0.13	0.00	0.38	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	17.91	3.58	2.28	0.65	0.65	0.33	0.98	0.00	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	22.74	6.50	3.84	2.07	0.30	1.18	0.00	0.89	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	24.77	11.10	2.99	1.71	0.28	1.14	0.14	0.28	0.00	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	30.09	7.32	5.04	2.11	0.49	1.63	0.65	0.16	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	24.96	4.26	0.91	1.22	0.00	0.30	0.00	0.00	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	16.16	5.56	5.30	1.26	0.25	0.76	0.00	0.00	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	20.98	1.91	2.38	1.91	0.00	0.48	0.00	0.00	0.48	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	26.40	10.18	6.05	3.39	0.44	1.18	0.29	0.00	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	31.86	9.26	5.38	2.15	1.08	2.37	0.00	0.00	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	23.72	9.55	5.14	2.31	0.73	1.47	0.31	0.10	0.10	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	13.77	4.95	4.18	2.94	1.08	0.46	0.00	0.15	0.46	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	22.64	5.39	1.08	2.16	1.08	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	17.93	2.69	4.18	3.59	0.60	0.60	0.00	0.00	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	41.65	12.63	8.88	3.07	0.34	2.05	0.34	0.68	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	26.54	5.73	5.50	1.65	0.47	0.71	0.16	0.08	0.24	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	19.32	4.23	3.12	2.21	0.81	0.81	0.10	0.00	1.01	1.31
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	13.20	3.64	3.64	1.37	0.46	1.37	0.68	0.23	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	30.19	6.04	4.23	4.23	0.60	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	25.70	7.68	4.50	3.97	0.79	2.12	1.32	0.00	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	50.07	16.64	13.72	16.64	6.79	5.86	1.46	0.53	2.26	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	45.96	14.90	11.39	12.65	6.76	3.63	0.50	0.13	1.25	2.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	12.43	5.33	5.83	1.27	0.51	1.27	0.76	0.25	0.76	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	14.93	3.62	3.77	1.96	0.15	0.60	0.00	0.00	0.00	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	13.50	4.50	1.50	0.75	0.00	0.75	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	58.15	1.29	11.63	0.00	0.00	1.29	1.29	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	26.97	9.30	6.05	1.40	0.47	0.93	0.00	0.00	0.93	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	14.64	2.52	1.01	1.51	0.00	1.51	0.00	0.00	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	16.92	2.82	3.76	2.82	0.94	0.31	0.00	0.31	0.31	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	16.81	2.95	1.47	1.47	0.29	0.88	0.59	0.29	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	17.16	6.08	3.33	1.08	0.58	0.58	0.08	0.08	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	23.83	7.47	3.27	0.93	0.00	1.87	0.00	0.00	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	34.25	14.82	6.33	7.92	1.87	4.17	0.43	0.29	1.15	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	37.73	13.26	8.92	3.57	2.04	1.27	0.25	0.00	0.51	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	39.86	9.40	4.32	2.26	0.38	1.69	0.19	0.00	0.38	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	35.77	8.52	5.59	4.19	1.82	0.84	0.28	0.00	0.28	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	39.38	17.85	5.87	4.44	2.01	3.18	0.25	0.08	0.08	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	24.29	2.86	1.43	0.00	0.00	0.48	0.00	0.00	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	31.56	18.10	7.34	6.61	2.20	3.43	0.00	0.24	0.98	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	41.76	11.27	7.07	8.84	1.10	1.77	0.00	0.00	1.55	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	10.83	3.80	2.34	0.29	0.00	0.29	0.59	0.00	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	45.67	8.94	5.05	1.94	0.00	1.17	0.00	0.00	1.17	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	19.57	2.91	3.97	1.32	0.53	1.32	0.26	0.00	0.26	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	10.79	2.23	5.21	2.23	0.37	2.60	0.00	0.00	1.12	3.35
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	25.87	2.87	4.67	9.34	1.44	1.08	0.00	0.00	0.00	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	29.81	5.68	3.12	6.53	0.57	1.99	1.14	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	38.21	3.15	2.76	2.76	0.39	0.79	1.18	0.39	0.79	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	12.70	3.56	2.54	1.02	0.00	0.51	0.00	0.51	0.76	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	30.35	7.59	3.59	1.20	0.00	0.00	0.00	0.00	0.80	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	17.14	4.18	2.09	1.25	0.42	1.25	0.00	0.42	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	22.92	4.58	1.38	1.38	0.46	0.92	0.46	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	49.49	17.17	10.94	10.10	3.87	4.38	1.68	1.18	0.34	0.67
Synoviocyte, donor2	11368-117I9	15.92	5.20	1.68	3.18	0.67	0.84	0.17	0.17	0.67	0.17
Synoviocyte, donor3	11440-118H9	25.92	6.48	3.80	0.67	0.22	0.67	0.22	0.00	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	53.60	8.58	11.08	2.14	0.36	1.43	0.36	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	23.78	3.96	1.98	1.98	0.00	0.00	0.00	0.00	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	47.93	11.58	6.48	1.16	0.23	0.69	0.69	0.23	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	13.05	2.94	1.36	0.14	0.22	0.22	0.36	0.00	0.22	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	14.30	6.19	1.55	0.39	0.00	0.39	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	14.32	7.44	1.15	1.15	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	27.19	10.21	8.73	4.06	3.32	1.60	2.34	1.72	0.62	0.98
Urethra, donor2	10319-105A4	77.33	8.99	7.19	5.40	3.60	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	27.10	5.58	3.72	1.59	0.27	0.80	0.53	0.27	0.27	0.00
Urothelial Cells, donor2	11600-120H7	26.84	7.21	1.60	1.60	0.40	0.00	0.00	0.00	0.00	0.40
Urothelial Cells, donor3	11681-122H7	27.28	5.04	3.44	0.23	0.46	0.00	0.46	0.23	0.46	0.00
Urothelial cells, donor0	11216-116B1	34.77	14.93	3.34	1.34	0.22	0.89	0.22	0.00	0.67	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	0.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	10.98	2.71	3.58	0.86	0.37	0.37	0.00	0.00	0.00	0.12
Wilms' tumor cell line:HFWT	10597-108E3	64.24	9.68	3.52	2.64	0.00	0.88	0.88	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	14.80	1.12	0.28	0.00	0.00	0.28	0.00	0.00	0.28	0.28
achilles tendon, donor2	10292-104G4	26.86	4.13	4.13	0.00	0.00	0.00	2.07	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	1.39	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.00	0.00	0.00	0.00	0.00	0.00	0.54	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.00	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	0.24	0.24	0.00	0.00	0.00	0.00	0.24	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	20.44	0.00	1.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	1.51	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	485.49	134.96	29.99	41.24	1.87	7.50	20.62	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	18.77	4.03	2.79	1.71	0.78	0.31	2.02	0.47	0.47	0.93
adipose, donor1	10184-103D4	56.30	18.18	7.62	0.59	2.93	2.35	0.59	0.00	5.86	7.62
adipose, donor2	10185-103D5	55.15	10.95	5.27	4.87	6.08	0.81	0.81	0.00	1.22	2.03
adipose, donor3	10186-103D6	76.79	13.07	8.44	4.90	4.36	2.45	1.36	0.00	4.63	2.18
adipose, donor4	10187-103D7	57.21	8.67	58.94	1.73	0.87	0.87	0.00	0.00	2.60	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	31.25	3.95	7.58	0.79	0.32	0.95	0.16	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	80.03	14.55	7.28	14.55	10.91	0.00	10.91	10.91	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	109.69	18.22	24.30	16.79	2.50	4.29	0.00	0.00	0.36	1.07
amniotic membrane cells, donor1	12235-129G3	8.81	2.32	1.62	0.93	0.23	0.23	0.00	0.23	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	8.79	0.68	5.07	0.34	0.00	0.00	0.00	0.68	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	7.66	0.59	0.59	0.00	0.29	0.00	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	60.48	10.67	8.30	3.56	0.00	4.74	10.67	2.37	0.00	0.00
amygdala, adult, donor10252	10151-102I7	50.69	19.26	5.47	1.42	4.87	4.06	6.29	2.84	0.61	0.41
amygdala, newborn, donor10223	10360-105E9	50.67	3.87	2.90	1.94	1.61	1.61	6.46	2.26	0.32	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	35.53	12.48	2.29	1.02	0.76	0.76	0.13	0.38	0.89	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	17.65	7.50	2.87	2.21	0.22	0.44	0.88	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	47.10	12.36	7.01	0.67	0.33	0.00	0.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	18.44	2.94	1.96	0.98	1.18	0.39	0.78	0.00	0.39	0.00
appendix, adult	10189-103D9	24.84	5.05	3.88	1.16	1.16	0.78	0.78	0.39	2.33	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	41.27	6.19	7.57	2.75	1.72	1.72	2.75	1.38	0.34	0.00
artery, adult	10190-103E1	5.43	4.08	6.79	0.00	1.36	0.00	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	15.79	3.48	2.75	0.29	0.00	0.43	0.00	0.00	0.14	0.00
b cell line:RPMI1788	10427-106D4	56.66	19.78	9.96	5.06	1.78	1.34	5.50	3.12	0.45	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	37.73	17.20	9.43	9.43	3.88	2.77	2.22	0.83	1.11	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	12.60	2.78	2.18	0.40	0.10	0.40	2.58	0.50	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	12.39	4.02	0.84	0.50	0.33	0.67	0.00	0.33	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	23.68	5.43	4.02	1.52	1.30	0.76	0.54	0.11	0.76	0.98
blood, adult, pool1	10053-101G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.99	3.43	5.99	0.86	0.00	0.86	0.86	0.00	0.86	0.00
bone marrow, adult	10192-103E3	26.32	2.02	3.37	2.02	0.67	1.35	2.70	0.67	0.00	1.35
brain, adult, donor1	10084-102B3	37.93	3.08	6.15	1.03	3.08	1.03	3.08	1.03	2.05	2.05
brain, adult, pool1	10012-101C3	16.26	5.68	3.90	1.89	3.23	2.67	3.45	0.45	0.45	0.11
brain, fetal, pool1	10085-102B4	125.56	18.70	2.67	2.67	0.00	8.01	24.04	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	22.13	3.96	2.31	0.33	0.99	0.99	0.99	0.00	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	1.00	0.00	0.12	0.00	0.00	0.00	0.12	0.00	0.12	0.00
breast, adult, donor1	10080-102A8	46.09	10.10	5.68	4.42	0.63	0.63	0.63	2.53	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	7.24	1.78	1.02	0.13	0.13	0.25	0.13	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	29.38	3.71	4.64	0.31	0.00	0.62	0.00	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	1.15	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	32.92	6.54	5.33	0.97	0.24	2.18	0.00	0.00	0.00	0.48
carcinoid cell line:NCI-H1770	10703-109H1	32.91	7.05	1.88	0.00	0.00	0.94	0.47	0.47	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	24.28	7.98	2.52	0.88	0.11	1.09	0.33	0.11	0.11	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	13.31	2.54	0.32	0.00	0.00	0.00	1.27	0.00	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	59.62	6.12	7.19	1.86	0.80	1.06	1.86	1.06	0.53	0.80
caudate nucleus - adult, donor10196	10177-103C6	57.57	11.51	5.76	1.15	2.30	0.00	2.30	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	26.44	14.72	3.01	3.35	6.02	3.51	0.50	0.50	0.67	0.33
caudate nucleus, adult, donor10258	10379-105H1	24.45	7.64	6.11	3.06	3.06	0.76	1.53	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	43.95	3.30	5.13	2.20	2.20	0.00	2.20	2.20	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	40.79	11.65	5.83	0.00	2.91	2.91	5.83	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	16.01	8.11	1.49	0.85	1.71	1.28	0.21	0.64	0.64	0.21
cerebellum, adult, pool1	10083-102B2	12.76	2.07	2.07	1.38	2.07	1.38	0.34	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	58.95	1.66	14.95	6.64	3.32	0.83	0.00	0.00	0.83	0.83
cerebral meninges, adult	10188-103D8	24.71	5.29	2.77	1.76	1.76	0.76	3.28	0.50	0.76	0.25
cerebrospinal fluid, donor2	10294-104G6	23.39	5.12	0.73	0.73	1.46	2.19	0.73	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	38.68	16.53	10.35	4.60	3.45	2.59	0.14	0.00	1.01	0.58
cervical cancer cell line:ME-180	10553-107I4	0.83	0.50	0.17	0.00	0.00	0.00	0.17	0.00	0.00	0.00
cervix, adult, pool1	10013-101C4	26.56	7.35	6.51	1.57	1.05	0.94	1.15	0.10	0.84	1.26
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	44.59	12.82	11.29	3.20	1.53	4.04	0.28	0.28	0.56	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	120.18	15.68	9.14	1.31	3.92	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	4.10	0.62	0.62	0.00	0.00	0.25	0.12	0.00	0.12	0.12
choriocarcinoma cell line:SCH	10785-110H2	14.29	3.20	2.09	1.23	0.37	0.25	0.25	0.12	0.25	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	9.49	2.13	0.00	0.24	0.00	0.00	0.00	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	5.41	2.28	1.71	0.57	0.00	0.28	0.00	0.00	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	53.39	27.14	9.84	11.83	3.38	4.47	2.19	1.29	4.87	5.27
chorionic membrane cells, donor3	12240-129G8	5.49	3.30	0.55	0.55	0.00	0.00	0.00	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	42.24	19.01	5.28	2.53	0.21	2.11	5.70	0.63	0.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	0.00	0.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	37.27	15.64	9.12	1.82	0.52	1.82	4.69	1.04	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	38.63	5.94	14.40	2.97	0.69	0.91	1.83	0.69	0.00	0.23
clear cell carcinoma cell line:TEN	10636-108I6	35.92	12.84	6.07	1.56	1.21	1.74	0.00	0.00	0.17	0.52
colon carcinoma cell line:CACO-2	10513-107D9	41.73	14.46	13.18	4.03	1.83	1.10	3.29	0.92	0.73	0.00
colon carcinoma cell line:COLO-320	10420-106C6	47.13	18.62	13.68	1.52	0.38	1.90	0.38	0.00	0.00	0.38
colon, adult, donor1	10082-102B1	57.12	5.95	14.28	2.38	5.95	1.19	2.38	0.00	1.19	1.19
colon, adult, pool1	10014-101C5	24.44	7.99	2.35	1.41	0.71	0.35	0.82	0.59	1.53	1.18
colon, fetal, donor1	10070-101I7	63.65	17.92	5.56	4.94	0.62	1.85	0.00	0.62	1.85	1.24
common myeloid progenitor CMP, donor1	12130-128D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	11.90	2.55	7.65	2.55	0.85	0.42	1.70	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	8.30	1.96	4.68	1.36	0.30	0.00	0.91	0.15	0.00	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	8.04	1.55	3.67	0.85	0.14	0.28	0.99	0.42	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	26.65	10.06	5.31	3.76	4.98	2.54	1.33	0.55	0.11	0.44
cruciate ligament, donor2	10295-104G7	29.99	1.62	6.48	1.62	3.24	1.62	0.81	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	47.35	16.85	4.01	0.80	12.84	0.80	1.61	0.80	0.00	0.00
diencephalon, adult	10193-103E4	16.08	2.16	2.88	1.44	2.40	0.96	0.48	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.92	0.46	0.00	0.00	0.00	0.00	0.23	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	20.00	4.87	5.39	0.77	0.00	1.03	0.26	0.00	0.51	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	5.06	2.17	1.20	0.72	0.00	0.24	0.00	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	30.40	10.47	6.48	4.98	1.50	1.99	0.00	1.00	1.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	44.65	7.20	12.96	2.88	2.88	1.44	1.44	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	41.93	7.36	17.66	10.30	2.21	2.21	0.74	0.74	0.00	0.74
dura mater, adult, donor1	10041-101F5	35.68	11.40	5.04	2.56	1.73	2.31	2.64	0.33	0.33	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	11.99	3.33	1.55	0.44	2.22	0.22	0.67	0.44	0.22	1.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	17.63	4.73	3.44	1.29	0.57	0.57	0.43	0.14	0.43	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	32.68	3.70	1.85	1.23	0.00	0.62	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	11.20	1.21	3.33	0.00	0.00	0.00	0.30	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	19.76	2.16	2.78	0.00	0.31	0.62	0.00	0.00	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	28.90	3.94	3.94	1.31	1.31	1.31	2.63	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	31.17	9.72	5.36	1.68	1.01	0.34	3.02	1.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	1.81	0.54	0.72	0.36	0.00	0.00	0.00	0.00	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	16.24	2.89	4.99	1.61	0.16	0.32	0.32	0.00	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	4.62	1.32	0.22	0.11	0.00	0.22	0.00	0.00	0.00	0.00
epididymis, adult	10197-103E8	47.51	8.37	10.05	3.56	3.98	1.47	4.19	10.26	2.93	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	16.68	3.90	3.73	1.60	0.71	0.18	0.00	0.35	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	0.52	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	0.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.10	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	0.45	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
esophagus, adult, pool1	10015-101C6	12.42	3.93	1.27	0.21	0.53	0.21	0.53	0.11	0.42	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	2.25	0.63	1.63	0.00	0.00	0.13	0.13	0.00	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	43.46	4.83	2.41	2.41	0.00	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	25.25	0.00	4.21	2.10	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	29.76	1.49	4.46	1.49	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	30.96	2.29	5.73	1.15	0.00	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	13.12	4.37	2.91	0.00	0.00	1.46	1.46	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	35.34	7.88	7.12	2.54	3.05	0.76	1.02	0.25	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	18.72	4.23	2.56	0.51	0.26	0.26	0.00	0.00	0.13	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	19.94	2.37	2.37	0.00	0.00	0.24	0.00	0.00	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	27.02	8.35	4.22	3.19	3.75	4.79	7.51	1.31	0.09	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	27.32	6.31	3.60	0.60	0.90	0.30	1.80	0.30	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	13.90	4.21	3.29	0.27	0.09	1.01	0.09	0.00	0.27	0.18
gall bladder, adult	10198-103E9	31.39	7.00	3.14	2.17	0.97	1.45	1.21	0.48	0.97	0.00
gamma delta positive T cells, donor1	11937-126A2	0.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	6.97	2.75	1.90	0.21	0.84	0.42	1.27	0.21	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	41.39	10.06	7.16	1.35	1.16	1.35	0.97	0.19	0.19	0.39
gastric cancer cell line:AZ521	10549-107H9	15.90	3.61	12.79	2.62	1.15	1.64	0.66	0.16	0.49	0.16
gastric cancer cell line:GSS	10560-108A2	64.98	8.24	9.15	2.75	0.00	0.92	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	153.07	23.07	22.85	16.22	14.16	11.88	7.08	7.54	2.06	0.69
giant cell carcinoma cell line:LU65	10487-107B1	1.61	0.00	0.00	0.00	0.00	0.00	0.23	0.00	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	13.58	3.92	2.80	0.42	0.28	0.28	0.28	0.00	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	29.18	3.74	3.49	1.25	1.25	0.50	1.00	0.00	0.75	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	25.33	5.28	14.36	4.12	0.95	3.06	0.21	0.00	0.21	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	20.36	7.16	11.09	4.35	1.12	1.97	0.14	0.00	0.00	0.28
glioblastoma cell line:T98G	10485-107A8	19.98	6.18	6.29	3.09	0.88	1.55	0.00	0.00	0.11	0.11
glioma cell line:GI-1	10413-106B8	20.79	9.66	3.22	2.05	0.00	0.59	0.00	0.00	1.46	0.88
globus pallidus - adult, donor10196	10175-103C4	38.63	7.29	4.37	3.64	6.56	1.46	0.73	0.00	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	31.49	13.43	3.66	1.71	4.15	2.69	0.49	0.24	0.49	0.00
globus pallidus, adult, donor10258	10367-105F7	30.12	2.74	1.37	4.11	5.48	0.00	0.00	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	37.30	3.73	6.40	3.20	2.13	1.07	1.07	0.53	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	58.88	11.52	12.16	5.12	0.96	2.56	0.96	0.64	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	49.58	6.43	7.35	1.38	0.00	1.84	0.00	0.46	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	51.21	5.94	3.20	0.91	0.00	2.29	0.46	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	48.31	4.51	5.15	2.58	0.00	0.00	0.00	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	47.43	0.00	4.31	0.00	0.00	0.00	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	49.38	4.80	7.54	1.37	0.00	0.69	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	32.00	2.21	5.52	7.72	1.10	0.00	3.31	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	18.83	4.48	3.89	0.90	2.69	1.20	1.49	0.00	0.90	0.90
heart - pulmonic valve, adult	10206-103F8	15.69	5.49	2.35	1.05	0.52	0.78	0.52	0.00	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	25.81	5.83	4.16	3.33	2.50	0.83	0.00	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	11.84	2.65	2.65	0.20	0.41	0.20	0.61	0.00	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	12.35	1.28	1.70	0.43	1.28	0.00	0.43	0.43	0.00	0.85
heart, adult, pool1	10016-101C7	8.74	1.15	0.92	0.92	0.00	0.69	0.69	0.00	0.23	0.00
heart, fetal, pool1	10046-101G1	56.37	12.32	10.47	2.88	6.16	1.03	1.75	0.92	0.41	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	118.78	28.38	14.50	10.18	6.79	4.01	0.00	0.31	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	134.38	13.08	11.89	5.95	3.57	3.57	2.38	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	50.72	20.00	14.70	16.35	19.01	4.64	7.62	5.86	0.66	0.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	45.39	21.85	13.59	18.93	18.57	8.01	8.25	4.85	0.24	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	52.24	23.95	15.76	19.30	17.79	7.07	8.08	4.75	0.51	0.71
hepatoma cell line:Li-7	10484-107A7	6.23	4.34	1.89	0.78	0.22	0.44	0.11	0.00	0.22	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	61.51	5.68	6.62	0.95	0.00	0.95	5.68	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	38.78	20.00	5.71	3.47	4.90	3.06	3.67	1.02	0.20	0.20
hippocampus, adult, donor10258	10374-105G5	52.78	2.49	6.97	3.49	1.00	3.49	5.98	1.49	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	42.65	2.11	2.82	4.93	1.06	0.70	3.88	1.06	0.00	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	50.66	5.49	6.71	2.44	0.61	0.61	0.61	0.00	1.83	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	58.51	6.48	7.27	0.79	0.00	0.79	0.59	0.00	1.37	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	52.56	9.39	6.09	1.02	0.00	0.76	0.51	0.00	1.02	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	121.23	18.04	6.77	0.00	0.56	0.00	1.13	0.56	9.59	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	111.81	22.98	7.49	1.03	0.52	3.36	0.77	0.77	8.78	4.39
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	83.51	14.80	6.45	1.14	0.38	1.90	1.14	0.00	6.07	2.66
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	81.75	13.43	8.47	5.84	2.92	2.63	1.17	0.88	5.26	7.01
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	102.54	18.74	10.77	5.17	8.40	3.88	2.59	0.00	6.03	5.60
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	88.00	9.18	15.01	4.17	3.34	2.50	1.67	0.42	3.75	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	39.07	6.16	8.05	3.79	3.08	0.95	1.18	0.00	1.42	2.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	81.80	15.43	7.71	6.27	5.30	1.93	1.45	0.48	2.25	3.21
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	55.21	8.08	10.10	4.04	2.02	3.37	1.35	0.00	1.35	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	37.87	9.70	4.38	1.56	0.94	1.10	0.16	0.16	1.56	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	35.37	4.42	5.40	0.49	0.98	0.98	0.49	0.00	0.98	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	23.56	6.11	3.49	1.75	0.00	0.87	0.00	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	97.36	21.19	7.06	3.44	1.34	2.67	1.15	0.00	8.97	5.54
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	87.65	19.19	6.54	3.05	0.00	2.18	0.00	0.00	3.05	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	63.97	16.99	5.00	0.00	0.50	1.50	0.00	0.00	3.00	4.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	51.81	8.85	7.16	1.13	6.03	0.75	0.38	0.00	4.14	3.01
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	50.02	8.18	3.18	2.73	5.46	0.45	0.91	0.00	5.46	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	38.53	7.20	3.76	2.19	2.51	0.31	1.88	0.00	1.88	2.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	42.62	7.02	8.49	3.43	2.61	0.98	1.14	0.33	1.63	2.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	42.97	8.71	7.26	2.61	4.94	1.74	0.58	0.29	2.61	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	45.44	6.58	7.77	2.39	2.09	1.49	1.79	0.30	2.99	2.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	56.16	8.13	4.43	1.29	0.37	1.29	0.55	0.37	2.03	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	66.47	10.84	4.56	2.00	0.29	0.86	0.86	0.00	1.71	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	51.04	9.80	2.45	1.22	0.00	0.00	0.00	0.00	0.41	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	94.01	15.49	7.04	2.82	0.70	2.46	0.35	1.06	6.34	3.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	101.99	12.99	4.75	1.90	0.63	1.58	0.32	0.00	3.80	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	85.04	9.08	5.45	3.63	0.30	2.12	0.61	0.61	7.57	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	66.19	4.65	6.72	2.59	2.59	1.55	2.07	0.00	2.59	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	71.07	6.64	2.66	5.98	2.66	0.66	1.99	0.66	1.33	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	43.35	6.93	6.67	4.62	1.03	1.54	1.80	0.26	0.51	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	53.17	8.69	7.41	3.32	2.81	2.05	1.53	0.77	0.77	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	56.03	6.82	12.12	2.27	2.27	0.76	0.76	0.00	3.79	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	55.45	6.05	9.07	5.38	1.68	2.35	3.02	1.01	2.69	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	63.03	8.45	5.31	2.42	0.24	0.97	0.24	0.00	0.97	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	53.48	6.24	5.79	2.23	0.00	0.89	0.45	0.00	2.23	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	57.07	7.80	5.37	0.98	0.00	1.95	0.98	0.00	2.44	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	129.89	20.78	9.17	2.44	1.22	1.83	0.31	0.61	5.81	4.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	107.36	22.77	6.51	6.51	0.00	3.25	0.00	0.00	39.04	19.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	75.79	13.24	6.95	2.98	0.00	2.98	0.66	0.33	8.94	5.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	100.16	14.23	7.11	5.47	6.02	0.55	0.55	0.55	3.83	3.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	70.93	7.24	7.96	2.90	5.07	2.17	0.72	0.36	2.17	4.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	69.75	11.03	9.96	3.20	3.20	1.42	0.36	0.00	3.91	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	70.41	3.58	4.77	7.16	1.19	2.39	0.00	0.00	2.39	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	67.17	10.97	10.29	5.69	4.33	2.44	1.63	0.27	4.47	3.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	71.12	9.43	7.54	4.04	0.81	0.54	0.81	0.00	1.89	1.89
immature langerhans cells, donor1	11904-125F5	9.69	2.66	1.70	1.21	0.00	0.73	0.24	0.48	0.00	0.24
immature langerhans cells, donor2	11905-125F6	15.05	0.79	0.79	0.79	0.00	0.79	0.79	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	38.89	11.55	7.95	3.50	3.41	6.53	9.08	2.46	0.47	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	5.20	0.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.65
kidney, adult, pool1	10017-101C8	56.87	19.73	11.11	9.21	8.01	6.21	2.90	3.00	1.50	1.40
kidney, fetal, pool1	10045-101F9	120.25	39.26	27.87	20.87	18.82	8.35	8.28	10.82	1.13	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	9.52	1.70	3.27	0.43	0.14	0.57	0.00	0.00	0.28	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	1.11	0.28	0.28	0.00	0.00	0.00	0.00	0.00	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	31.75	6.06	2.20	0.92	0.73	1.28	1.47	0.55	0.00	0.00
left atrium, adult, donor1	10079-102A7	15.80	3.27	0.54	0.54	1.63	0.54	0.54	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	8.09	3.03	1.52	0.51	0.51	0.00	0.00	1.01	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	17.60	3.59	3.23	1.08	1.08	1.08	0.00	0.00	0.72	1.44
leiomyoma cell line:15242A	10570-108B3	15.22	1.63	3.26	4.35	1.63	0.00	0.00	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	17.48	2.91	4.86	3.64	1.46	1.46	0.00	0.00	0.24	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	33.46	7.32	6.27	1.05	0.00	2.09	0.00	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	10.63	4.25	1.65	0.94	0.00	0.12	0.24	0.00	0.12	0.00
liposarcoma cell line:KMLS-1	10782-110G8	29.84	6.40	8.12	2.66	0.78	2.19	0.62	0.00	0.31	0.31
liposarcoma cell line:SW 872	10726-110A6	119.77	34.85	16.08	9.99	3.90	4.87	0.37	0.00	0.85	0.49
liver, adult, pool1	10018-101C9	28.52	11.67	13.29	18.96	5.02	6.97	1.94	3.08	2.76	3.08
liver, fetal, pool1	10086-102B5	32.92	6.58	7.53	8.47	1.88	0.00	2.82	4.70	3.76	0.94
locus coeruleus - adult, donor10196	10182-103D2	49.14	9.77	5.25	3.94	4.52	1.90	1.75	0.58	0.58	0.29
locus coeruleus, adult, donor10252	10165-103B3	24.91	13.84	3.88	3.51	4.06	3.69	1.85	0.55	0.00	0.18
locus coeruleus, adult, donor10258	10375-105G6	44.58	9.87	5.64	3.10	4.23	1.41	1.41	1.13	0.56	0.85
locus coeruleus, newborn, donor10223	10362-105F2	19.77	4.21	6.31	2.52	1.26	0.42	1.26	0.42	1.68	2.10
lung adenocarcinoma cell line:A549	10499-107C4	4.43	1.25	0.42	0.00	0.00	0.14	0.55	0.14	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	37.23	6.89	5.52	0.69	0.00	2.07	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	34.93	8.17	3.69	0.79	0.00	0.66	0.13	0.13	0.26	0.00
lung, adult, pool1	10019-101D1	28.94	8.98	6.85	1.77	2.95	1.65	2.95	1.18	1.06	2.24
lung, fetal, donor1	10068-101I5	86.48	10.85	26.54	11.13	4.00	3.42	4.28	2.00	0.86	0.57
lung, right lower lobe, adult, donor1	10075-102A3	74.69	16.95	8.25	5.04	3.67	4.12	4.12	2.29	1.37	3.21
lymph node, adult, donor1	10077-102A5	16.57	5.68	0.95	0.47	0.47	0.00	0.47	0.47	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	8.30	1.81	2.57	0.00	0.00	0.30	1.36	0.45	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	2.55	0.00	0.85	0.00	0.00	0.85	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	15.98	1.33	0.00	0.89	0.44	0.44	0.44	0.44	0.44	0.00
mature adipocyte, donor2	12232-129F9	9.55	3.94	1.25	0.83	0.21	0.42	0.21	0.42	0.42	0.00
mature adipocyte, donor3	12233-129G1	5.45	3.08	1.66	0.24	0.00	0.24	0.71	0.24	0.47	0.00
mature adipocyte, donor4	12234-129G2	7.11	0.79	1.58	0.53	0.26	0.53	0.53	0.26	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	46.22	9.29	13.82	4.05	2.86	2.38	1.67	0.48	0.48	1.67
medial frontal gyrus - adult, donor10196	10170-103B8	33.84	4.51	6.77	3.38	2.26	2.26	2.26	2.26	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	32.92	11.59	4.78	1.66	3.13	3.31	4.60	0.37	0.92	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	37.80	4.13	3.81	1.59	0.95	1.59	2.54	0.95	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	59.28	6.82	8.53	2.99	0.00	4.69	7.68	2.56	0.85	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	39.32	7.93	5.06	1.35	1.69	2.70	5.06	0.51	0.00	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	31.83	11.67	4.46	2.12	4.03	4.67	3.82	1.06	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	32.75	3.85	0.00	5.78	0.00	1.93	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	80.40	6.46	6.46	3.23	0.72	3.23	11.84	4.31	1.08	1.08
medulla oblongata - adult, donor10196	10174-103C3	47.38	3.24	2.60	1.95	1.95	0.65	1.95	0.00	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	27.40	12.38	3.87	2.17	2.48	2.79	0.93	0.62	0.77	0.31
medulla oblongata, adult, pool1	10038-101F2	32.73	11.59	5.63	4.82	7.84	2.20	2.20	0.65	0.08	0.16
medulla oblongata, newborn, donor10223	10361-105F1	51.04	2.08	9.72	4.86	2.78	2.78	0.35	1.39	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	147.46	34.32	19.93	4.87	0.00	2.21	2.44	0.44	0.89	0.89
medulloblastoma cell line:ONS-76	10759-110E3	7.34	0.86	0.24	0.24	0.12	0.24	0.00	0.00	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	8.91	2.16	2.01	1.15	0.29	0.14	0.29	0.14	0.00	0.43
melanoma cell line:G-361	10465-106H6	31.49	7.87	8.14	2.17	1.90	0.81	0.81	0.00	1.09	0.81
meningioma cell line:HKBMM	10691-109F7	6.87	1.99	1.09	0.00	0.18	0.00	0.00	0.00	0.54	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	24.67	3.52	0.88	0.00	0.00	0.00	1.76	0.00	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	21.00	6.74	2.07	1.30	0.00	0.26	2.59	0.52	0.00	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	11.66	2.92	4.60	2.76	0.15	0.92	0.15	0.15	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	26.36	6.73	3.27	2.36	0.55	0.91	0.00	0.00	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.46	1.66	0.83	2.48	0.00	1.24	0.41	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	14.61	5.06	1.83	1.40	0.42	0.56	0.14	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	10.01	3.47	1.35	0.58	0.39	0.58	0.39	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	10.41	3.47	2.78	0.69	0.00	1.39	0.00	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	7.04	3.09	0.86	0.34	0.17	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	11.16	2.42	1.84	0.69	0.23	0.69	0.00	0.12	0.23	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	11.14	2.25	3.32	1.19	0.27	0.53	0.00	0.00	0.13	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	11.07	4.46	2.30	1.49	0.41	0.41	0.27	0.00	0.27	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	27.17	5.83	5.41	2.13	0.43	1.71	0.14	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	12.52	1.98	2.31	0.99	0.00	0.33	0.00	0.00	0.00	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	19.93	5.26	4.43	2.35	0.97	0.69	0.14	0.00	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	18.15	3.49	2.79	0.70	0.35	0.35	0.00	0.35	0.70	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	17.35	8.17	3.06	0.82	1.02	0.41	0.20	0.00	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	36.66	5.39	7.55	4.31	1.80	2.16	1.80	1.08	1.08	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	20.28	4.24	3.10	0.83	0.21	0.72	0.00	0.00	0.31	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	16.42	1.60	2.96	0.91	0.46	0.68	0.00	0.00	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	16.78	2.52	6.29	2.52	0.42	1.68	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	21.07	6.13	4.48	2.99	1.34	1.05	0.45	0.30	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	20.48	3.59	3.15	0.96	0.09	0.44	0.00	0.00	0.18	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	29.82	7.00	4.42	1.10	0.37	0.74	0.37	0.37	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	42.64	7.44	7.44	8.58	3.43	2.29	0.57	0.86	0.29	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	31.58	3.79	6.32	3.37	0.00	1.26	0.42	0.42	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	26.03	3.65	7.31	5.48	1.37	0.00	0.46	0.00	0.00	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	21.49	6.14	4.09	3.33	1.02	0.26	0.00	0.00	0.51	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	31.41	7.59	3.14	2.62	0.26	1.31	0.00	0.00	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	28.65	3.08	3.70	4.01	1.23	0.31	0.92	0.00	0.00	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	29.42	4.71	6.12	2.82	0.71	0.24	0.00	0.00	0.47	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	29.45	4.06	2.71	3.38	0.00	0.68	0.68	0.68	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	25.15	5.11	5.50	2.75	1.18	0.39	0.39	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	23.17	3.71	4.63	0.93	0.46	0.46	0.00	0.93	0.93	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	28.26	5.48	4.90	3.46	0.87	1.44	0.58	0.00	0.58	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	23.43	5.58	4.46	2.01	1.34	0.67	0.22	0.22	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	32.93	5.05	6.73	3.36	2.40	0.48	0.00	0.00	0.48	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	35.20	5.87	5.13	3.67	1.47	2.93	0.73	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	21.82	2.69	4.70	3.36	0.00	0.67	0.34	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	25.38	4.91	2.05	0.41	0.00	0.41	0.00	0.82	0.82	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	32.65	1.72	2.58	3.01	0.43	0.43	0.00	0.00	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	41.02	2.73	10.94	2.73	2.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	0.00	15.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	30.21	4.87	3.57	1.95	0.97	1.30	0.32	0.32	0.32	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	34.92	2.91	4.36	1.45	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	44.25	6.93	6.93	5.33	1.07	1.07	0.53	0.00	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	29.44	6.54	7.36	3.27	0.82	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	27.21	3.89	7.39	3.50	0.78	0.00	0.00	0.00	0.78	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	31.48	0.00	2.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	36.76	2.98	8.94	9.93	0.00	0.99	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	0.00	14.30	0.00	0.00	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	26.68	3.56	4.15	2.37	0.59	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	35.34	1.22	1.22	6.09	0.00	0.00	1.22	0.00	0.00	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	40.54	5.70	5.70	2.53	0.00	0.00	1.27	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	27.25	3.45	3.45	1.72	0.00	1.03	0.69	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	0.00	2.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	7.98	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	6.89	3.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	13.04	4.07	2.85	1.63	0.00	0.00	0.00	0.00	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	23.04	11.12	3.97	2.38	0.00	0.79	0.00	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	8.25	2.95	1.18	0.00	0.00	0.00	0.00	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	9.35	2.49	1.56	0.62	0.00	0.94	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	17.38	1.34	1.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	16.56	2.37	7.10	2.37	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	0.00	2.57	2.57	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	11.70	4.82	3.44	2.75	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	16.33	1.98	0.99	1.48	0.00	0.49	0.49	0.00	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	1.12	2.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	15.90	4.45	2.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	13.70	1.61	2.82	1.61	0.81	0.81	0.40	0.40	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	0.00	2.18	2.18	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	24.07	0.00	1.27	1.27	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	12.14	1.21	2.43	1.21	0.61	0.00	0.00	0.61	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	4.52	0.00	4.52	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	8.24	4.94	1.65	0.82	0.00	0.00	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	12.70	2.58	1.39	0.60	0.00	0.20	0.20	0.00	0.40	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	13.95	3.57	2.92	0.97	0.00	0.00	0.00	0.00	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	15.28	4.07	2.04	4.07	1.02	2.04	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	51.84	12.38	13.15	5.42	0.77	0.77	4.64	2.32	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	31.42	8.03	5.43	2.36	0.00	0.94	0.00	0.00	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	14.36	5.10	4.87	3.24	0.46	1.16	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	4.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	11.71	3.19	2.06	2.06	0.10	0.41	0.10	0.00	0.10	0.10
mesothelioma cell line:Mero-25	10850-111F4	21.33	5.22	1.36	1.82	0.00	1.59	0.00	0.00	0.45	0.00
mesothelioma cell line:Mero-41	10851-111F5	15.65	1.71	2.20	1.22	0.00	0.98	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	23.91	5.09	7.09	1.77	0.22	1.99	0.00	0.00	0.66	0.00
mesothelioma cell line:Mero-82	10853-111F7	11.56	1.31	1.84	0.79	0.26	0.26	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	20.43	3.92	3.06	0.68	0.34	1.19	0.17	0.00	0.68	0.68
mesothelioma cell line:Mero-84	10855-111F9	28.31	4.30	4.55	1.77	0.51	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	15.94	3.52	3.93	1.04	0.00	1.24	0.00	0.00	0.00	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	59.14	14.58	13.58	2.32	0.83	2.98	0.00	0.00	0.00	1.16
mesothelioma cell line:NCI-H226	10846-111E9	22.44	5.43	3.80	1.27	0.00	1.09	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	8.03	0.51	0.85	0.51	0.00	0.51	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	94.66	16.79	25.19	15.78	3.05	4.33	8.65	9.92	1.02	0.76
mesothelioma cell line:No36	10857-111G2	12.72	1.63	1.63	0.33	0.00	0.65	0.00	0.00	0.65	0.00
mesothelioma cell line:ONE58	10858-111G3	18.97	1.90	1.63	1.35	0.00	0.54	0.00	0.00	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	57.96	12.28	20.73	10.56	0.96	2.88	6.91	2.11	1.34	1.15
migratory langerhans cells, donor2	11902-125F3	88.66	20.64	23.32	11.48	0.73	3.54	6.11	2.93	1.22	0.73
migratory langerhans cells, donor3	11903-125F4	94.77	24.95	27.10	9.87	0.72	2.15	11.13	7.54	1.26	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	38.20	8.81	1.96	0.33	0.65	0.65	0.00	0.00	0.00	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	28.61	6.57	4.66	0.42	1.27	0.42	0.00	0.00	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	27.41	8.29	2.30	0.92	0.46	0.46	0.92	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	4.07	1.11	0.92	0.18	0.00	0.00	0.00	0.37	0.00	0.00
myeloma cell line:PCM6	10474-106I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	40.08	6.09	4.57	3.55	1.52	0.51	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	17.46	6.28	2.16	0.78	0.20	1.18	0.39	0.20	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	8.80	2.45	0.45	0.22	0.00	0.33	0.00	0.00	0.11	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	8.82	2.35	0.74	0.22	0.07	0.00	0.15	0.00	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	10.49	2.76	8.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	54.29	15.18	15.41	2.53	0.00	1.38	2.76	0.00	0.00	0.46
neuroblastoma cell line:NB-1	10539-107G8	55.75	20.02	14.59	4.68	1.12	2.25	1.12	0.00	0.19	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	78.87	16.66	2.32	1.90	0.42	1.27	3.37	1.27	1.05	0.42
neuroblastoma cell line:NH-12	10555-107I6	84.79	22.55	9.13	1.49	0.19	1.68	1.12	0.37	0.75	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	23.72	2.14	0.95	0.00	0.00	0.00	0.00	0.47	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	30.25	5.23	1.43	0.00	0.00	0.32	1.58	0.48	0.16	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	33.81	11.27	4.23	1.01	0.20	0.20	4.23	1.81	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	71.84	7.63	1.27	0.00	0.00	0.00	8.26	1.91	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	76.66	13.57	10.11	6.92	1.86	2.66	0.80	0.53	0.00	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	54.29	15.90	5.41	0.34	0.17	0.51	2.20	0.17	0.51	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	12.01	4.80	4.00	0.80	1.60	4.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	47.45	16.99	5.77	5.13	2.24	2.89	0.32	0.00	0.32	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	63.59	26.28	16.82	20.23	15.77	6.04	0.79	0.26	0.26	0.79
nucleus accumbens, adult, pool1	10037-101F1	25.87	9.09	5.91	3.09	5.53	4.78	6.19	1.22	0.47	0.09
occipital cortex - adult, donor10196	10172-103C1	57.69	2.06	6.18	2.06	4.12	0.00	8.24	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	35.96	13.95	7.51	1.07	3.76	4.83	5.90	1.88	0.27	0.27
occipital cortex, newborn, donor10223	10355-105E4	68.42	3.64	5.10	1.82	0.73	2.91	7.28	3.28	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	36.21	6.82	4.72	2.36	3.15	2.10	6.30	1.31	1.31	1.84
occipital lobe, fetal, donor1	10073-102A1	181.08	29.61	24.89	8.58	2.15	5.15	26.18	9.01	0.86	0.43
occipital pole, adult, pool1	10036-101E9	21.29	7.65	3.71	2.05	3.31	3.47	5.20	1.10	0.16	0.16
olfactory region, adult	10195-103E6	39.74	7.26	5.73	2.48	4.59	2.67	6.11	1.15	0.57	0.19
optic nerve, donor1	10277-104E7	40.02	14.01	4.00	2.00	0.00	2.00	0.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	12.19	4.21	1.37	0.11	0.00	0.23	0.00	0.00	0.68	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	16.21	4.95	2.20	0.00	0.27	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	1.85	0.69	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	57.03	13.23	10.88	3.82	1.18	2.94	0.00	0.00	1.18	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	38.31	11.21	14.95	1.87	0.00	4.67	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	26.08	3.39	4.03	3.61	0.64	1.48	0.85	0.85	0.42	0.00
ovary, adult, pool1	10020-101D2	21.93	6.99	4.37	1.66	0.52	0.70	0.61	0.17	0.61	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	18.88	5.13	1.28	0.18	0.00	0.00	0.18	0.00	0.00	0.00
pancreas, adult, donor1	10049-101G4	46.09	18.81	14.11	4.70	4.70	3.76	3.76	2.82	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	3.35	0.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	15.33	3.58	0.85	0.17	0.00	0.00	0.51	0.00	0.34	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	30.80	6.13	4.64	1.49	0.50	1.32	2.81	1.32	0.50	0.50
paracentral gyrus, adult, pool1	10035-101E8	18.85	7.14	4.30	2.38	4.48	3.20	4.76	1.19	0.09	0.09
parietal cortex, adult, donor10258	10373-105G4	19.82	3.67	18.35	0.73	0.00	0.73	3.67	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	32.92	3.76	7.52	1.88	1.88	0.94	2.82	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	29.64	9.98	4.56	1.43	2.57	4.28	4.28	0.00	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	21.06	7.23	5.02	2.20	2.73	3.79	5.20	0.79	0.53	0.44
parietal lobe, fetal, donor1	10072-101I9	183.30	23.28	24.25	2.91	2.91	0.97	15.52	4.85	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	64.68	7.48	4.86	2.62	1.50	4.11	10.09	2.62	1.12	0.37
parotid gland, adult	10199-103F1	53.03	17.27	8.02	2.47	1.23	3.70	0.62	1.85	1.23	0.00
penis, adult	10200-103F2	26.86	6.98	2.15	1.07	2.15	1.07	1.07	1.07	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	4.65	0.37	0.56	0.19	0.00	0.00	0.00	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	30.60	6.26	3.21	0.58	0.73	0.73	1.89	0.00	0.15	0.00
pineal gland - adult, donor10196	10179-103C8	61.28	4.52	9.03	4.52	3.87	0.65	5.16	1.94	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	21.91	4.74	5.33	1.78	1.18	1.78	4.74	2.96	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	53.30	3.76	10.66	4.39	3.14	0.00	1.88	0.63	0.63	1.25
pituitary gland - adult, donor10196	10180-103C9	55.65	8.09	6.07	3.04	3.04	2.02	3.04	3.04	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	56.29	19.28	19.80	2.61	6.78	5.21	7.30	3.65	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	43.41	6.81	8.51	2.55	4.26	1.70	7.66	0.85	5.11	0.00
placenta, adult, pool1	10021-101D3	16.34	5.16	6.02	2.26	1.94	0.43	2.37	0.65	0.54	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	11.52	2.78	3.31	0.66	0.13	0.00	1.19	0.53	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	19.45	10.74	5.29	1.56	0.78	2.02	1.09	0.93	0.78	0.00
pons, adult, pool1	10033-101E6	12.05	5.59	2.58	2.67	1.38	1.55	1.03	0.34	0.17	0.09
postcentral gyrus, adult, pool1	10032-101E5	22.75	6.97	5.49	2.09	3.49	3.40	5.49	1.13	0.09	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	7.72	1.46	2.77	0.00	0.00	0.73	0.15	0.00	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	18.51	3.81	2.72	1.27	0.18	0.54	0.73	0.54	0.00	0.18
prostate, adult, pool1	10022-101D4	32.65	8.16	5.26	2.18	1.27	1.36	0.82	0.91	0.63	0.73
putamen, adult, donor10196	10176-103C5	25.26	12.04	2.36	2.60	5.67	0.94	1.65	0.24	0.24	0.24
putamen, adult, donor10252	10152-102I8	15.69	3.92	0.00	1.96	3.92	1.96	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	16.39	1.09	2.19	3.28	1.09	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	20.54	7.01	1.93	3.38	1.93	0.72	0.97	0.24	0.00	0.00
putamen, newborn, donor10223	10365-105F5	12.74	1.50	1.50	0.00	0.00	2.25	3.00	0.75	1.50	0.75
rectal cancer cell line:TT1TKB	10469-106I1	3.78	0.58	0.29	0.00	0.00	0.00	0.00	0.00	0.29	0.00
rectum, fetal, donor1	10067-101I4	89.02	13.91	23.65	12.52	2.78	1.39	0.00	2.78	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	32.22	6.15	8.90	2.12	0.64	1.70	0.42	0.00	0.21	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	21.12	7.04	3.31	0.83	0.41	0.41	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	43.44	12.62	7.36	3.48	2.19	1.59	1.09	1.59	0.70	0.30
retinoblastoma cell line:Y79	10475-106I7	27.80	8.57	3.38	0.78	0.26	1.30	0.26	0.00	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	42.18	12.37	7.87	2.25	0.28	1.69	0.00	0.00	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	92.46	21.98	9.85	8.34	4.55	1.52	0.00	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	10.52	1.94	2.27	0.32	0.00	0.32	0.00	0.00	0.00	0.00
salivary acinar cells, donor2	11772-123I8	0.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor3	11773-123I9	2.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	52.62	14.87	5.72	2.86	6.86	4.58	3.43	4.58	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	19.98	5.14	4.30	0.93	0.34	0.84	0.76	0.17	0.00	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	18.69	3.41	4.00	1.29	0.00	0.71	0.82	0.47	0.47	0.47
seminal vesicle, adult	10201-103F3	29.10	7.94	11.11	3.70	2.65	3.17	3.70	1.06	0.53	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	35.47	8.26	9.96	3.40	0.24	1.94	4.13	2.92	0.00	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	24.16	4.28	2.26	0.25	0.00	0.25	0.00	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	42.15	6.02	3.01	1.00	0.00	3.01	0.00	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	62.73	27.27	8.73	6.72	2.42	3.90	0.13	0.13	0.27	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	16.91	5.97	2.76	0.88	0.55	0.99	1.44	0.66	0.11	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	10.71	3.35	5.81	2.06	0.52	0.77	2.71	0.65	0.26	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	13.48	0.71	2.13	0.00	1.42	0.00	0.71	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	7.80	3.24	1.08	0.36	1.20	0.36	0.24	0.00	0.24	0.48
skeletal muscle, fetal, donor1	10066-101I3	58.29	8.04	5.03	4.02	10.05	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	20.36	20.36	6.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	77.01	15.78	13.89	1.89	0.00	0.63	4.42	0.63	0.00	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	107.73	34.35	12.01	5.67	6.34	2.33	9.01	4.00	1.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	40.66	6.62	8.51	1.89	0.32	1.89	0.32	0.00	0.63	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	22.17	4.63	6.17	0.77	0.00	0.96	1.93	0.00	0.19	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	27.69	13.19	2.97	1.65	0.99	1.15	0.66	0.00	0.00	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	48.42	9.17	1.77	0.16	0.00	0.16	1.13	0.00	0.00	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	27.24	7.41	5.88	1.31	1.09	0.65	2.40	0.22	0.44	0.22
small intestine, adult, pool1	10024-101D6	12.42	3.22	3.94	0.96	0.36	0.24	0.72	0.12	0.36	0.36
small intestine, fetal, donor1	10064-101I1	28.50	3.44	6.14	2.95	1.72	0.98	0.49	0.49	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	17.44	5.64	7.18	1.03	2.56	1.54	0.51	1.03	0.00	1.03
smooth muscle, adult, pool1	10048-101G3	35.93	6.72	3.10	1.81	5.69	0.78	0.52	0.26	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	34.04	5.90	2.14	0.54	0.27	0.27	0.00	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	67.45	10.09	4.59	5.74	5.28	2.06	1.15	0.69	0.46	0.00
spinal cord, adult, donor10252	10159-103A6	19.32	7.89	3.15	1.97	1.18	2.37	0.39	0.79	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	49.12	4.15	2.08	5.53	1.38	0.69	2.08	2.08	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	58.54	10.98	14.03	7.93	5.49	0.61	3.05	1.22	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	31.69	5.51	6.43	4.13	0.92	1.38	0.00	0.46	0.00	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	67.81	17.33	7.62	6.72	2.99	2.09	1.19	0.60	0.15	0.30
spleen, adult, pool1	10025-101D7	17.62	5.95	3.63	0.66	0.11	1.54	1.21	1.54	0.22	0.44
spleen, fetal, pool1	10044-101F8	23.36	7.79	6.83	2.94	0.64	0.87	3.42	1.27	0.64	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	7.35	2.59	1.24	0.41	0.00	0.10	1.04	0.21	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	5.89	1.14	0.76	0.19	0.00	0.00	0.00	0.00	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	11.53	0.35	2.45	0.35	1.05	0.35	0.35	0.00	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	19.55	5.47	1.17	0.78	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	7.32	2.81	1.35	0.34	0.45	0.45	0.11	0.00	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	6.78	1.69	0.00	0.42	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	33.00	8.04	4.65	1.69	0.42	0.00	1.27	0.00	0.42	0.42
stomach, fetal, donor1	10062-101H8	103.59	18.16	12.82	3.20	2.14	0.00	4.27	3.20	0.00	0.00
submaxillary gland, adult	10202-103F4	53.55	14.81	5.70	2.85	0.57	1.71	3.42	0.57	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	18.49	8.72	2.49	0.83	1.04	0.62	1.25	0.21	0.00	0.21
substantia nigra, adult, donor10258	10371-105G2	47.07	4.14	3.10	6.72	1.55	2.59	2.07	1.55	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	62.18	2.83	9.19	3.53	2.12	1.41	0.00	0.00	2.12	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	16.97	4.13	3.90	1.60	0.00	0.69	0.23	0.23	0.23	0.23
temporal lobe, adult, pool1	10031-101E4	29.42	8.31	6.87	2.71	2.88	3.90	5.59	0.76	0.51	0.59
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	196.59	38.46	9.97	2.14	0.71	3.56	17.09	5.70	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	162.63	20.66	13.63	2.64	0.44	4.83	13.19	5.27	1.76	0.00
tenocyte, donor1	11763-123H8	37.35	12.57	5.24	3.14	0.00	1.40	0.35	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	40.06	9.54	6.87	2.67	1.14	1.91	0.76	0.00	0.00	0.38
tenocyte, donor3	11768-123I4	44.11	8.90	7.41	6.30	1.85	2.97	0.74	0.74	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	57.45	8.67	1.53	0.51	1.19	1.36	0.51	0.00	0.85	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	34.68	9.87	3.55	2.00	0.62	0.92	2.00	0.31	0.46	0.46
teratocarcinoma cell line:PA-1	10807-111A6	42.93	13.79	2.94	0.77	0.31	0.77	0.77	0.00	0.15	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	23.36	4.19	2.16	1.02	0.25	0.38	0.00	0.00	0.76	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	15.13	1.51	1.13	0.38	0.00	0.00	0.00	0.00	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	8.40	2.07	1.20	0.44	0.33	0.11	0.00	0.22	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	43.32	8.79	7.17	1.95	1.95	1.30	0.33	0.00	0.00	0.98
testis, adult, pool1	10026-101D8	12.56	4.51	2.47	1.40	0.32	0.54	0.86	0.11	0.64	1.18
testis, adult, pool2	10096-102C6	23.91	0.90	4.96	0.45	1.35	1.80	0.90	2.71	0.45	0.00
thalamus - adult, donor10196	10168-103B6	45.26	2.21	3.31	2.21	1.10	2.21	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	24.85	11.72	3.28	2.19	2.97	3.59	1.25	0.31	0.31	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	46.19	4.62	1.54	9.24	1.54	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	34.75	4.61	1.65	2.31	2.31	0.66	1.32	0.16	0.00	0.16
thalamus, newborn, donor10223	10366-105F6	20.14	1.73	5.18	4.03	0.00	1.73	2.88	0.00	0.58	0.00
throat, adult	10209-103G2	20.47	4.24	3.75	2.00	2.00	1.50	1.50	0.50	0.00	0.50
throat, fetal, donor1	10061-101H7	62.46	11.27	18.89	6.09	17.98	1.22	4.57	3.96	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	35.37	4.97	2.19	0.20	0.00	0.60	0.00	0.00	0.20	0.00
thymus, adult, pool1	10027-101D9	4.08	1.09	1.09	0.40	0.00	0.10	0.89	0.10	0.10	0.00
thymus, fetal, pool1	10043-101F7	7.69	2.18	2.08	0.31	0.73	0.31	0.62	0.42	0.21	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	37.63	6.12	2.53	1.33	0.00	0.40	1.33	0.13	0.53	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	57.27	16.20	2.93	1.68	1.26	0.98	4.47	0.84	0.28	0.28
thyroid, adult, pool1	10028-101E1	66.63	15.30	8.40	3.83	9.80	1.31	2.33	2.15	1.59	1.21
thyroid, fetal, donor1	10060-101H6	90.44	8.44	20.04	8.44	21.09	1.32	2.64	1.32	0.26	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	61.59	9.24	18.48	0.00	12.32	0.00	0.00	0.00	0.00	3.08
tongue, adult	10203-103F5	7.91	1.86	2.09	0.70	0.00	0.47	0.47	0.00	0.23	0.23
tongue, fetal, donor1	10059-101H5	22.46	3.94	2.76	2.36	3.15	0.79	0.00	0.39	0.79	0.39
tonsil, adult, pool1	10047-101G2	8.21	4.11	1.50	0.60	0.60	0.70	0.90	0.60	0.00	0.10
trachea, adult, pool1	10029-101E2	25.11	8.59	4.01	1.23	0.90	1.64	1.39	0.33	0.57	0.57
trachea, fetal, donor1	10058-101H4	44.24	12.69	11.54	5.00	5.77	3.08	1.92	1.15	0.00	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	43.58	9.21	7.79	9.92	3.19	2.13	0.35	0.00	0.71	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	59.27	19.86	8.61	1.32	1.01	2.23	4.46	0.91	0.30	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	18.02	6.89	3.45	1.57	0.00	0.63	1.25	0.63	0.78	0.31
tridermal teratoma cell line:HGRT	10694-109G1	171.23	15.22	11.42	1.90	3.81	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	18.96	5.16	3.05	0.85	0.51	0.76	0.34	0.25	0.17	0.00
umbilical cord, fetal, donor1	10057-101H3	37.56	6.26	4.17	0.00	4.17	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	42.15	7.85	15.70	4.44	1.71	0.68	0.85	0.34	0.17	0.00
uterus, fetal, donor1	10055-101H1	56.31	11.77	20.48	10.24	3.07	1.54	1.54	0.51	0.00	1.02
vagina, adult	10204-103F6	37.48	9.69	2.58	1.94	3.88	0.65	0.65	0.00	0.65	0.00
vein, adult	10191-103E2	14.91	1.75	1.53	0.66	0.22	0.22	0.66	0.22	0.22	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00